Alternative functional criteria to assess airflow-limitation reversibility in asthma

array:20 ["pii" => "X087321591593305X" "issn" => "08732159" "doi" => "10.1016/j.rppnen.2014.08.002" "estado" => "S300" "fechaPublicacion" => "2015-03-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Rev Port Pneumol. 2015;21:69-75" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 4901 "formatos" => array:3 [ "EPUB" => 250 "HTML" => 3496 "PDF" => 1155 ] ] "itemSiguiente" => array:16 [ "pii" => "X0873215915933068" "issn" => "08732159" "doi" => "10.1016/j.rppnen.2014.05.005" "estado" => "S300" "fechaPublicacion" => "2015-03-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Rev Port Pneumol. 2015;21:76-81" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 14072 "formatos" => array:3 [ "EPUB" => 301 "HTML" => 11081 "PDF" => 2690 ] ] "en" => array:11 [ "idiomaDefecto" => true "titulo" => "Inspiratory muscle training with threshold or incentive spirometry: Which is the most effective?" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "76" "paginaFinal" => "81" ] ] "contieneResumen" => array:1 [ "en" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig1" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "figura" => array:1 [ 0 => array:4 [ "imagen" => "320v21n02-90393306fig1.jpg" "Alto" => 965 "Ancho" => 1558 "Tamanyo" => 125668 ] ] "descripcion" => array:1 [ "en" => "Effects of inspiratory muscular training in groups studied. Comparison between pre-IMT at 15 days in threshold group ¿ TG (* p < 0.001) and incentive spirometry group ¿ ISG (* p < 0.001), and at 30 days in TG (** p < 0.001) and ISG (** p < 0.001). Comparison between the three groups in pre-IMT ( # p = 0.494), 15 days ( ## p < 0.001) and 30 days ( ### p < 0.001) conditions. Difference between the TG and ISG at 15 days ( + p = 0.328) and at 30 days ( ++ p = 0.045). CG: control group; TG: threshold group; ISG: incentive spirometry group. ANOVA two-way test followed by Bonferroni multiple comparison. Significance was accepted at p < 0.05." ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Dulciane Nunes Paiva, Laíse Bender Assmann, Diogo Fanfa Bordin, Ricardo Gass, Renan Trevisan Jost, Mario Bernardo-Filho, Rodrigo Alves França, Dannuey Machado Cardoso" "autores" => array:8 [ 0 => array:2 [ "nombre" => "Dulciane Nunes" "apellidos" => "Paiva" ] 1 => array:2 [ "nombre" => "Laíse Bender" "apellidos" => "Assmann" ] 2 => array:2 [ "nombre" => "Diogo Fanfa" "apellidos" => "Bordin" ] 3 => array:2 [ "nombre" => "Ricardo" "apellidos" => "Gass" ] 4 => array:2 [ "nombre" => "Renan Trevisan" "apellidos" => "Jost" ] 5 => array:2 [ "nombre" => "Mario" "apellidos" => "Bernardo-Filho" ] 6 => array:2 [ "nombre" => "Rodrigo Alves" "apellidos" => "França" ] 7 => array:2 [ "nombre" => "Dannuey Machado" "apellidos" => "Cardoso" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0873215915933068?idApp=UINPBA00004E" "url" => "/08732159/0000002100000002/v0_201604141148/X0873215915933068/v0_201604141148/en/main.assets" ] "itemAnterior" => array:16 [ "pii" => "X0873215915933041" "issn" => "08732159" "doi" => "10.1016/j.rppnen.2014.04.009" "estado" => "S300" "fechaPublicacion" => "2015-03-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Rev Port Pneumol. 2015;21:61-8" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 8278 "formatos" => array:3 [ "EPUB" => 275 "HTML" => 5851 "PDF" => 2152 ] ] "en" => array:11 [ "idiomaDefecto" => true "titulo" => "Validation of a Portuguese version of the STOP-Bang questionnaire as a screening tool for obstructive sleep apnea: Analysis in a sleep clinic" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "61" "paginaFinal" => "68" ] ] "contieneResumen" => array:1 [ "en" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig1" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "figura" => array:1 [ 0 => array:4 [ "imagen" => "320v21n02-90393304fig1.jpg" "Alto" => 977 "Ancho" => 1505 "Tamanyo" => 95319 ] ] "descripcion" => array:1 [ "en" => "Distribution of patients according to their STOP-Bang score." ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "R. Reis, F. Teixeira, V. Martins, L. Sousa, L. Batata, C. Santos, J. Moutinho" "autores" => array:7 [ 0 => array:2 [ "Iniciales" => "R." "apellidos" => "Reis" ] 1 => array:2 [ "Iniciales" => "F." "apellidos" => "Teixeira" ] 2 => array:2 [ "Iniciales" => "V." "apellidos" => "Martins" ] 3 => array:2 [ "Iniciales" => "L." "apellidos" => "Sousa" ] 4 => array:2 [ "Iniciales" => "L." "apellidos" => "Batata" ] 5 => array:2 [ "Iniciales" => "C." "apellidos" => "Santos" ] 6 => array:2 [ "Iniciales" => "J." "apellidos" => "Moutinho" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0873215915933041?idApp=UINPBA00004E" "url" => "/08732159/0000002100000002/v0_201604141148/X0873215915933041/v0_201604141148/en/main.assets" ] "en" => array:14 [ "idiomaDefecto" => true "titulo" => "Alternative functional criteria to assess airflow-limitation reversibility in asthma" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "69" "paginaFinal" => "75" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "A. Tavares e Castro, P. Matos, B. Tavares, M.J. Matos, A. Segorbe-Luís" "autores" => array:5 [ 0 => array:4 [ "Iniciales" => "A." "apellidos" => "Tavares e Castro" "email" => array:1 [ 0 => "anafilomena@hotmail.com" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "a" "identificador" => "affa" ] 1 => array:2 [ "etiqueta" => "*" "identificador" => "cor1" ] ] ] 1 => array:3 [ "Iniciales" => "P." "apellidos" => "Matos" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "a" "identificador" => "affa" ] ] ] 2 => array:3 [ "Iniciales" => "B." "apellidos" => "Tavares" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "b" "identificador" => "affb" ] ] ] 3 => array:3 [ "Iniciales" => "M.J." "apellidos" => "Matos" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "a" "identificador" => "affa" ] ] ] 4 => array:3 [ "Iniciales" => "A." "apellidos" => "Segorbe-Luís" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "b" "identificador" => "affb" ] ] ] ] "afiliaciones" => array:2 [ 0 => array:3 [ "entidad" => "Pulmonology Unit, Hospitais da Universidade de Coimbra, Centro Hospitalar Universitário de Coimbra, Coimbra, Portugal" "etiqueta" => "a" "identificador" => "affa" ] 1 => array:3 [ "entidad" => "Immunoallergology Unit, Hospitais da Universidade de Coimbra, Centro Hospitalar Universitário de Coimbra, Coimbra, Portugal" "etiqueta" => "b" "identificador" => "affb" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor1" "etiqueta" => "*" "correspondencia" => "Corresponding author. anafilomena@hotmail.com" ] ] ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig1" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "figura" => array:1 [ 0 => array:4 [ "imagen" => "320v21n02-90393305fig1.jpg" "Alto" => 2638 "Ancho" => 2546 "Tamanyo" => 666320 ] ] "descripcion" => array:1 [ "en" => "Receiver operating characteristic (ROC) curves were used to assess alternative pulmonary function tests variables that could define a positive bronchodilator response in a population of asthmatic patients. The area under the ROC curve (AUC) was significant (>0.070) for the following criteria: percentage change of PEF, FEF 25¿75% and sGaw; and absolute change of PEF and FEF 25¿75%. Cutt-off values were attained from the exact curve speck were sensitivity and specificity reached the best correlation: absolute PEF change ¿0.4 L/s; percentage PEF change ¿8%; absolute FEF 25¿75% change ¿0.087 L/s; percentage FEF 25¿75% change ¿27%; and percentage sGaw change ¿25%. PEF: peak expiratory flow; FEF 25¿75%: maximum mid-forced expiratory flow; IC: inspiratory capacity; Raw: airway resistance; sGaw: specific airway conductance." ] ] ] "textoCompleto" => "<a name="sec0005" class="elsevierStyleCrossRefs"></a>IntroductionAirway obstruction reversibility, evaluated by the bronchodilator response, is routinely assessed to assist and support the diagnosis of asthma.<a href="#bib26" class="elsevierStyleCrossRefs">1</a>, <a href="#bib27" class="elsevierStyleCrossRefs">2</a> The most recent guidelines published by the American Thoracic Society and the European Respiratory Society (ATS/ERS) in 2005 on reversibility testing define significant bronchodilator response as a 12% per cent increase from baseline and a 200 mL absolute increase in forced expiratory volume in 1 s (FEV1) and/or forced vital capacity (FVC).<a href="#bib28" class="elsevierStyleCrossRefs">3</a>However, there is considerable variation within the guidelines as to the degree of reversibility considered significant. The British Thoracic Society,<a href="#bib29" class="elsevierStyleCrossRefs">4</a> for example, recommends at least 15% increase of baseline FEV1 while the Global Initiative for Asthma (GINA)<a href="#bib27" class="elsevierStyleCrossRefs">2</a> recommends at least 12% of baseline FEV1 for the bronchodilator response to be considered positive.Airway obstruction reversibility is still a controversial topic also because there is still a lack of consensus on which variables should be used to express bronchodilator response. In fact, despite the general use of FEV1 or FVC criteria, some studies have concluded that changes in these measurements can frequently underestimate significant responses to bronchodilator in both adults and children.<a href="#bib30" class="elsevierStyleCrossRefs">5</a>, <a href="#bib31" class="elsevierStyleCrossRefs">6</a>, <a href="#bib32" class="elsevierStyleCrossRefs">7</a>, <a href="#bib33" class="elsevierStyleCrossRefs">8</a>, <a href="#bib34" class="elsevierStyleCrossRefs">9</a>, <a href="#bib35" class="elsevierStyleCrossRefs">10</a>, <a href="#bib36" class="elsevierStyleCrossRefs">11</a>, <a href="#bib37" class="elsevierStyleCrossRefs">12</a>On the other hand, when reversibility is expressed by the percentage increase in FEV1, it shows bronchodilator responses more frequently in the most severely obstructed patients.<a href="#bib38" class="elsevierStyleCrossRefs">13</a>, <a href="#bib39" class="elsevierStyleCrossRefs">14</a>Also, when changes in FEV1 are not meaningful, alternative criteria such as decrease in lung hyperinflation, can establish a substantial response.<a href="#bib28" class="elsevierStyleCrossRefs">3</a>, <a href="#bib30" class="elsevierStyleCrossRefs">5</a>, <a href="#bib32" class="elsevierStyleCrossRefs">7</a> In the same way, absolute changes in peak expiratory flow (PEF) have proved to be a good substitute to establish airway obstruction reversibility in asthma.<a href="#bib40" class="elsevierStyleCrossRefs">15</a>Difficulties in performing a forced expiratory maneuver may further limit use of FEV1 or FVC, particularly in children and older patients. In these cases, criteria such as airway resistance (Raw) or specific airway conductance (sGaw) may be useful.<a href="#bib41" class="elsevierStyleCrossRefs">16</a>, <a href="#bib42" class="elsevierStyleCrossRefs">17</a>Assuming that the significant changes in other ventilatory parameters can explain the bronchodilator improvement of dyspnea even without significant changes in FEV1 and/or FVC, we performed the present study to investigate alternative criteria of positivity in a population of asthmatic patients with documented airway obstruction. Baseline and post-bronchodilator spirometry and body plethysmography were performed on all patients. Unusual pulmonary function variables – PEF, maximum mid-forced expiratory flow (FEF25–75%), total lung capacity (TLC), residual volume (RV), inspiratory capacity (IC), Raw and sGaw – which could possibly assess bronchodilator response were retrospectively collected and analyzed.<a name="sec0010" class="elsevierStyleCrossRefs"></a>Methods<a name="sec0015" class="elsevierStyleCrossRefs"></a>SubjectsOne hundred never-smoker asthmatic patients referred to our Pulmonary Physiology Laboratory by their immunoallergology or pulmonology physician were included in the present study. This population included two matched groups of 50 consecutive patients with and without a significant bronchodilator response defined according to the 2005 ATS/ERS guidelines. Patients under 20 years old, smokers, with severe asthma, recent asthma acute exacerbations or cardiovascular disease, were excluded.<a name="sec0020" class="elsevierStyleCrossRefs"></a>Lung function measurementsSpirometric measurements were made using a pneumotachograph (MasterScreen PTF Jaëger®). Plethysmography measurements were obtained through a body plethysmograph (MasterScreen Body Jaëger®). All spirometric and plethysmographic tests were performed according to accepted standards as recommended by the ATS.<a href="#bib43" class="elsevierStyleCrossRefs">18</a>, <a href="#bib44" class="elsevierStyleCrossRefs">19</a><a name="sec0025" class="elsevierStyleCrossRefs"></a>Reversibility testingAll medication likely to interfere with bronchomotricity was previously suspended.<a href="#bib43" class="elsevierStyleCrossRefs">18</a> Short- and long-acting β-agonists bronchodilators were suspended 4 h and 12 h prior to the test, respectively, while oral theophylines were stopped 12–24 h before. Patients were instructed not to smoke and avoid food containing caffeine (coffee, tea, cola) or theobromine (chocolate) for at least 1 h before the test.All patients underwent spirometric and lung volumes evaluation at baseline conditions. An obstructive ventilatory defect was defined by a FEV1/FVC ratio less than 0.70. Only those with verified airflow obstruction and three satisfactory records of FEV1, FVC and PEF were submitted to further challenge with bronchodilator. Airway-obstruction reversibility was tested 10 min after administration of four equal and separate doses of 100 μg (total dose 400 μg) of salbutamol given by a metered-dose inhaler connected to a space chamber device.<a href="#bib45" class="elsevierStyleCrossRefs">20</a>, <a href="#bib46" class="elsevierStyleCrossRefs">21</a><a name="sec0030" class="elsevierStyleCrossRefs"></a>Statistical analysisData analysis was performed by IBM SPSS® for Windows version 20.0. All patient demographic and clinical features were reported using frequency and descriptive analyses. Average and standard deviation (SD) scores were calculated for numerical variables, and number and percent for categorical variables. Pearson's chi-square and ordinary t-tests were used for comparison of means and proportions. Two-tailed p values of less than 0.05 were considered to indicate statistical significance. Paired t-tests were used to compare lung function parameters between those with and without criteria for reversibility of airway obstruction according to ATS/ERS criteria. Cut-off values were obtained from the exact value where there was ideal matching of both sensitivity and specificity values on ROC curves. Measurements evaluated were FEV1, FVC, PEF, FEF25–75%, RV, IC, Raw and sGaw.<a name="sec0035" class="elsevierStyleCrossRefs"></a>Results<a name="sec0040" class="elsevierStyleCrossRefs"></a>DemographicsDemographic data of the studied population are shown in <a href="#t0005" class="elsevierStyleCrossRefs">Table 1</a>. Compared to patients with a positive bronchodilator response, patients with no airway obstruction reversibility were older (62.1 versus 56.1 years old) and predominantly female, but these differences did not reach statistical significance. Body mass index was basically the same between both sets of asthmatic patients.Table 1. Demographic and lung function characteristics of patients with asthma.<a name="t0005" class="elsevierStyleCrossRefs"></a><table><tr align="left"><td> </td><td colspan="2">Reversibility of airway obstruction a</td><td>p value</td></tr><tr align="left"><td> </td><td>No (n = 50)</td><td>Yes (n = 50)</td><td> </td></tr><tr align="left"><td>Gender, n (%)</td><td> </td><td> </td><td>0.045</td></tr><tr align="left"><td>Male</td><td>18 (36)</td><td>28 (56.0)</td><td> </td></tr><tr align="left"><td>Female</td><td>32 (64.0)</td><td>22 (44.0)</td><td> </td></tr><tr align="left"><td colspan="4"> </td></tr><tr align="left"><td>Age, years</td><td>61.2 ± 11.9</td><td>56.1 ± 15.6</td><td>NS</td></tr><tr align="left"><td>BMI, kg/m2</td><td>28.4 ± 4.6</td><td>28.5 ± 5.7</td><td>NS</td></tr><tr align="left"><td>FEV1/FVC</td><td>0.6 ± 0.1</td><td>0.6 ± 0.1</td><td>0.029</td></tr><tr align="left"><td colspan="4"> </td></tr><tr align="left"><td colspan="4">FVC</td></tr><tr align="left"><td>Baseline, L</td><td>2.8 ± 1.0</td><td>3.1 ± 1.0</td><td>NS</td></tr><tr align="left"><td>Baseline, % of predicted</td><td>99.5 ± 17.9</td><td>92.2 ± 16.0</td><td>0.033</td></tr><tr align="left"><td>Post-bronchodilator, L</td><td>2.8 ± 1.1</td><td>3.4 ± 1.0</td><td>0.007</td></tr><tr align="left"><td>Post-bronchodilator change, L</td><td>0.0 ± 0.3</td><td>0.3 ± 0.2</td><td>0.000</td></tr><tr align="left"><td>Post-bronchodilator change, %</td><td>1.4 ± 3.4</td><td>10.8 ± 6.2</td><td>0.000</td></tr><tr align="left"><td colspan="4"> </td></tr><tr align="left"><td colspan="4">FEV1</td></tr><tr align="left"><td>Baseline, L</td><td>1.8 ± 0.7</td><td>1.9 ± 0.7</td><td>NS</td></tr><tr align="left"><td>Baseline, % of predicted</td><td>76.2 ± 16.1</td><td>67.6 ± 15.9</td><td>0.008</td></tr><tr align="left"><td>Post-bronchodilator, L</td><td>1.9 ± 0.7</td><td>2.1 ± 0.8</td><td>0.044</td></tr><tr align="left"><td>Post-bronchodilator change, L</td><td>0.1 ± 0.1</td><td>0.3 ± 0.2</td><td>0.000</td></tr><tr align="left"><td>Post-bronchodilator change, %</td><td>3.9 ± 5.1</td><td>18.5 ± 11.8</td><td>0.000</td></tr><tr align="left"><td colspan="4"> </td></tr><tr align="left"><td colspan="4">PEF</td></tr><tr align="left"><td>Baseline, L/s</td><td>4.7 ± 1.7</td><td>4.8 ± 1.6</td><td>NS</td></tr><tr align="left"><td>Baseline, % of predicted</td><td>73.1 ± 22.1</td><td>67.0 ± 16.7</td><td>NS</td></tr><tr align="left"><td>Post-bronchodilator, L/s</td><td>5.0 ± 1.9</td><td>5.7 ± 1.7</td><td>NS</td></tr><tr align="left"><td>Post-bronchodilator change, L/s</td><td>0.3 ± 0.5</td><td>0.8 ± 0.5</td><td>0.000</td></tr><tr align="left"><td>Post-bronchodilator change, %</td><td>5.6 ± 10.9</td><td>19.1 ± 12.6</td><td>0.000</td></tr><tr align="left"><td colspan="4"> </td></tr><tr align="left"><td colspan="4">FEF25–75%</td></tr><tr align="left"><td>Baseline, L/s</td><td>0.8 ± 0.5</td><td>0.8 ± 0.5</td><td>NS</td></tr><tr align="left"><td>Baseline, % of predicted</td><td>27.6 ± 15.0</td><td>23.8 ± 11.9</td><td>NS</td></tr><tr align="left"><td>Post-bronchodilator, L/s</td><td>0.9 ± 0.6</td><td>1.1 ± 0.7</td><td>NS</td></tr><tr align="left"><td>Post-bronchodilator change, L/s</td><td>0.5 ± 0.2</td><td>0.3 ± 0.3</td><td>0.009</td></tr><tr align="left"><td>Post-bronchodilator change, %</td><td>5.3 ± 23.9</td><td>39.4 ± 62.6</td><td>0.001</td></tr><tr align="left"><td colspan="4"> </td></tr><tr align="left"><td colspan="4">TLC</td></tr><tr align="left"><td>Baseline, L</td><td>5.5 ± 1.3</td><td>6.0 ± 1.4</td><td>NS</td></tr><tr align="left"><td>Baseline, % of predicted</td><td>108.3 ± 14.3</td><td>106.9 ± 14.1</td><td>NS</td></tr><tr align="left"><td>Post-bronchodilator, L</td><td>5.5 ± 1.2</td><td>6.0 ± 1.3</td><td>NS</td></tr><tr align="left"><td>Post-bronchodilator change, L</td><td>0.0 ± 0.2</td><td>0.0 ± 0.3</td><td>NS</td></tr><tr align="left"><td>Post-bronchodilator change, %</td><td>0.1 ± 4.6</td><td>1.0 ± 5.4</td><td>NS</td></tr><tr align="left"><td colspan="4"> </td></tr><tr align="left"><td colspan="4">RV</td></tr><tr align="left"><td>Baseline, L</td><td>3.1 ± 4.7</td><td>2.7 ± 0.8</td><td>NS</td></tr><tr align="left"><td>Baseline, % of predicted</td><td>122.8 ± 31.64</td><td>132.0 ± 31.70</td><td>NS</td></tr><tr align="left"><td>Post-bronchodilator, L</td><td>2.9 ± 3.7</td><td>2.4 ± 0.7</td><td>NS</td></tr><tr align="left"><td>Post-bronchodilator change, L</td><td>−0.2 ± 1.0</td><td>−0.2 ± 0.3</td><td>NS</td></tr><tr align="left"><td>Post-bronchodilator change, %</td><td>−2.7 ± 10.6</td><td>−7.2 ± 11.2</td><td>0.037</td></tr><tr align="left"><td colspan="4"> </td></tr><tr align="left"><td colspan="4">IC</td></tr><tr align="left"><td>Baseline, L</td><td>2.5 ± 0.8</td><td>2.5 ± 0.8</td><td>NS</td></tr><tr align="left"><td>Baseline, % of predicted</td><td>119.6 ± 25.7</td><td>102.0 ± 24.6</td><td>0.000</td></tr><tr align="left"><td>Post-bronchodilator, L</td><td>2.5 ± 0.8</td><td>3.0 ± 1.8</td><td>NS</td></tr><tr align="left"><td>Post-bronchodilator change, L</td><td>0.1 ± 0.2</td><td>0.5 ± 1.8</td><td>NS</td></tr><tr align="left"><td>Post-bronchodilator change, %</td><td>4.2 ± 9.2</td><td>11.2 ± 15.2</td><td>0.006</td></tr><tr align="left"><td colspan="4"> </td></tr><tr align="left"><td colspan="4">Raw</td></tr><tr align="left"><td>Baseline, kPa s/L</td><td>0.5 ± 0.2</td><td>0.5 ± 0.2</td><td>NS</td></tr><tr align="left"><td>Baseline, % of predicted</td><td>164.8 ± 78.5</td><td>170.8 ± 79.9</td><td>NS</td></tr><tr align="left"><td>Post-bronchodilator, kPa s/L</td><td>0.4 ± 1.2</td><td>0.3 ± 0.2</td><td>0.000</td></tr><tr align="left"><td>Post-bronchodilator change, kPa s/L</td><td>−0.1 ± 0.1</td><td>−0.2 ± 0.1</td><td>0.004</td></tr><tr align="left"><td>Post-bronchodilator change, %</td><td>−15.6 ± 18.5</td><td>−30.3 ± 20.4</td><td>NS</td></tr><tr align="left"><td colspan="4"> </td></tr><tr align="left"><td colspan="4">sGaw</td></tr><tr align="left"><td>Baseline, 1/(kPa s)</td><td>0.7 ± 0.3</td><td>0.7 ± 0.3</td><td>NS</td></tr><tr align="left"><td>Baseline, % of predicted</td><td>77.3 ± 37.8</td><td>70.9 ± 39.1</td><td>NS</td></tr><tr align="left"><td>Post-bronchodilator, 1/(kPa s)</td><td>0.9 ± 0.5</td><td>1.0 ± 0.5</td><td>NS</td></tr><tr align="left"><td>Post-bronchodilator change, 1/(kPa s)</td><td>0.2 ± 0.3</td><td>0.4 ± 0.3</td><td>0.002</td></tr><tr align="left"><td>Post-bronchodilator change, %</td><td>28.7 ± 27.9</td><td>65.4 ± 54.2</td><td>0.000</td></tr></table>a Reversibility of airway obstruction defined according to the ATS/ERS criteria of 2005. BMI: body mass index; FEV1: forced expiratory volume in one second; FVC: forced vital capacity; PEF: peak expiratory flow; FEF: forced expiratory flow; TLC: total lung capacity; RV: residual volume; IC: inspiratory capacity; Raw: airway resistance; sGaw: specific airway conductance; NS: not significant. <a name="sec0045" class="elsevierStyleCrossRefs"></a>Lung function and bronchodilator responseLung function characteristics between bronchodilator responders and non-responders are compared in <a href="#t0005" class="elsevierStyleCrossRefs">Table 1</a>. No meaningful variations could be found neither among any of the spirometry nor plethysmography baseline values or among the majority of the baseline percentage values of predicted between the two groups. There was a substantial difference between responders and non-responders regarding the baseline percentage values of predicted of FEV1, FVC and IC, with bronchodilator responders exhibiting significantly higher values among these particular variables.After the administration of a short-acting bronchodilator, there were important differences between the absolute change of FVC, FEV1, PEF and IC in the two groups. Also, significant percentage increases were observed in all these variables among the responder group. Absolute and percentage decreases occurred in both RV and Raw that were significantly greater in the responder group, but statistical power was found only for the absolute change of Raw and the percentage change of RV.Other changes were also important, like the percentage change of FEF25–75% and the absolute change of TLC.<a name="sec0050" class="elsevierStyleCrossRefs"></a>Alternative criteriaThe area under the ROC curve (AUC) was significant for the following criteria: percentage change of PEF, FEF25–75% and sGaw (0.795, 0.779 and 0.731, respectively), and absolute change of PEF and FEF25–75% (0.793 and 0.747, respectively). The AUC for the absolute and percentage changes of both RV and IC, and for the absolute change of sGaw were not significant. <a href="#f0005" class="elsevierStyleCrossRefs">Figure 1</a> and <a href="#t0010" class="elsevierStyleCrossRefs">Table 2</a> display graphic and numerical representation, respectively, of AUC values for alternative ventilatory criteria.<a name="f0005" class="elsevierStyleCrossRefs"></a><img src="320v21n02-90393305fig1.jpg" alt="Receiver operating characteristic (ROC) curves were used to assess alternative pulmonary function tests variables that could define a positive bronchodilator response in a population of asthmatic patients. The area under the ROC curve (AUC) was significant (>0.070) for the following criteria: percentage change of PEF, FEF25–75% and sGaw; and absolute change of PEF and FEF25–75%. Cutt-off values were attained from the exact curve speck were sensitivity and specificity reached the best correlation: absolute PEF change ≥0.4 L/s; percentage PEF change ≥8%; absolute FEF25–75% change ≥0.087 L/s; percentage FEF25–75% change ≥27%; and percentage sGaw change ≥25%. PEF: peak expiratory flow; FEF25–75%: maximum mid-forced expiratory flow; IC: inspiratory capacity; Raw: airway resistance; sGaw: specific airway conductance."></img>Figure 1. Receiver operating characteristic (ROC) curves were used to assess alternative pulmonary function tests variables that could define a positive bronchodilator response in a population of asthmatic patients. The area under the ROC curve (AUC) was significant (>0.070) for the following criteria: percentage change of PEF, FEF25–75% and sGaw; and absolute change of PEF and FEF25–75%. Cutt-off values were attained from the exact curve speck were sensitivity and specificity reached the best correlation: absolute PEF change ≥0.4 L/s; percentage PEF change ≥8%; absolute FEF25–75% change ≥0.087 L/s; percentage FEF25–75% change ≥27%; and percentage sGaw change ≥25%. PEF: peak expiratory flow; FEF25–75%: maximum mid-forced expiratory flow; IC: inspiratory capacity; Raw: airway resistance; sGaw: specific airway conductance.Table 2. Area under the ROC curve (AUC) for alternative lung function criteria to define positive bronchodilator responses.<a name="t0010" class="elsevierStyleCrossRefs"></a><table><tr align="left"><td>Variable</td><td>AUC</td></tr><tr align="left"><td>PEF, absolute change</td><td>0.793</td></tr><tr align="left"><td>PEF, % change</td><td>0.795</td></tr><tr align="left"><td>FEF25–75%, absolute change</td><td>0.747</td></tr><tr align="left"><td>FEF25–75%, % change</td><td>0.779</td></tr><tr align="left"><td>IC, absolute change</td><td>NS</td></tr><tr align="left"><td>IC, % change</td><td>NS</td></tr><tr align="left"><td>Raw, absolute change</td><td>NS</td></tr><tr align="left"><td>Raw, % change</td><td>NS</td></tr><tr align="left"><td>sGaw, absolute change</td><td>NS</td></tr><tr align="left"><td>sGaw, % change</td><td>0.731</td></tr></table>PEF: peak expiratory flow; FEF: forced expiratory flow; IC: inspiratory capacity; Raw: airway resistance; sGaw: specific airway conductance; NS: not significant. Since PEF is a parameter that depends on the individual ability to perform a forced expiratory maneuver, a correlation analysis between this variable and sGaw, an independent parameter, was undertaken and it showed a linear relationship between the two variables (R = 5.7).ROC analysis, specifically the best match point between sensitivity and specificity, defined the following cut-off values for the lung function variables with significant AUC: an absolute and percentage change of PEF ≥0.4 L/s and ≥8%; an absolute and percentage change of FEF25–75% ≥0.087 L/s and 27%; and a percentage change of sGaw ≥25%. The sensitivity and specificity values for each of these new variables were as follows: 83.7% and 70.0% for the absolute PEF change; 81.6% and 66.0% for the percentage PEF change; 74.0% and 68.0% for the absolute FEF25–75% change; 60% and 88.0% for the percentage change of FEF25–75%; and 84.0% and 56.0% for the percentage sGaw change.Based on the cut-off values defined by ROC analysis, it was found that a large part of the population of asthmatic patients with non-reversible bronchial obstruction according to the criteria of the ATS/ERS showed a positive response based on alternative criteria, seen in <a href="#f0010" class="elsevierStyleCrossRefs">Figure 2</a>. Hence, 47 patients (94%) of the total of 50 patients with positive bronchodilator response by the ATS/ERS criteria also had reversible bronchial obstruction by the new criteria. On the other hand, 36 patients (72%) of the total 50 patients with negative bronchodilator response were reclassified as positive bronchodilators according to at least one of the alternative new criteria. The percentage change of sGaw was the most responsible for detecting bronchodilatation, which was positive in 22 patients (44%), followed by the percentage change of PEF in 17 patients (34%) and the absolute change of FEF25–75% in 16 patients (32%). Finally, 10 patients (20%) had a positive absolute change of PEF while 6 patients (12%) had a positive percentage change of FEF25–75%.<a name="f0010" class="elsevierStyleCrossRefs"></a><img src="320v21n02-90393305fig2.jpg" alt="Alternative lung function criteria for assessing bronchodilatation in a population of asthmatic patients classified as negative bronchodilators according to ATS/ERS criteria. Patients without bronchodilatation according to ATS/ERS criteria (n = 50) were considered as positive bronchodilators according to new lung function criteria. A total of 36 patients (72%) had at least one positive criteria; 22 patients (44%) had a percentage change of sGaw ≥25%; 17 patients (34%) had a percentage change of PEF ≥8%; 16 patients (32%) had an absolute change of FEF25–75% ≥0.087 L/s; 10 patients (20%) had an absolute change of PEF ≥0.4 L/s; and 6 patients (12%) had a percentage change of FEF25–75% ≥27%. PEF: peak expiratory flow; FEF25–75%: maximum mid-forced expiratory flow; IC: inspiratory capacity; Raw: airway resistance; sGaw: specific airway conductance."></img>Figure 2. Alternative lung function criteria for assessing bronchodilatation in a population of asthmatic patients classified as negative bronchodilators according to ATS/ERS criteria. Patients without bronchodilatation according to ATS/ERS criteria (n = 50) were considered as positive bronchodilators according to new lung function criteria. A total of 36 patients (72%) had at least one positive criteria; 22 patients (44%) had a percentage change of sGaw ≥25%; 17 patients (34%) had a percentage change of PEF ≥8%; 16 patients (32%) had an absolute change of FEF25–75% ≥0.087 L/s; 10 patients (20%) had an absolute change of PEF ≥0.4 L/s; and 6 patients (12%) had a percentage change of FEF25–75% ≥27%. PEF: peak expiratory flow; FEF25–75%: maximum mid-forced expiratory flow; IC: inspiratory capacity; Raw: airway resistance; sGaw: specific airway conductance.<a name="sec0055" class="elsevierStyleCrossRefs"></a>DiscussionAsthma is a worldwide disease with an increasing incidence and significant burden. Although the diagnosis of asthma is primarily based on clinical grounds, measurement of pulmonary function and particularly the assessment of bronchodilator response is essential for the confirmation and assessment of the disease.<a href="#bib26" class="elsevierStyleCrossRefs">1</a>, <a href="#bib27" class="elsevierStyleCrossRefs">2</a>International guidelines define significant bronchodilator response as absolute and percentage changes in FEV1 and FVC, but these variables may be insufficient to identify all the asthmatic patients who exhibit some degree of airway obstruction reversibility.<a href="#bib47" class="elsevierStyleCrossRefs">22</a> Therefore, we aimed to determine the bronchodilator effects on other lung function parameters besides FEV1 and FVC, and its ability to detect functional responses to bronchodilator in asthmatic patients.The postbronchodilator percentage variation of PEF, FEF25–75% and sGaw had a significant value of AUC on ROC curves, which confirms its usefulness as alternative criteria of bronchodilator positivity. The same was also verified for the absolute change of PEF and FEF25–75% but not for absolute change of sGaw. The absolute and percentage changes in both RV and Raw did not prove to be good enough tests to assess bronchodilator response.Based on the cut-off values defined by the ROC curves, it was possible to show that a sizeable proportion (72%) of the asthmatic patients without reversibility of bronchial obstruction according to the criteria of the ATS/ERS 2005 guidelines had a positive response based on alternative criteria. The percentage change of sGaw was the most sensitive test for assessing bronchodilatation, followed by the absolute and percentage change of PEF. The absolute and percentage change of FEF25–75% were the least sensitive tests.Some of our findings do not entirely correlate with previous studies published by Light et al.<a href="#bib48" class="elsevierStyleCrossRefs">23</a> concerning Raw and sGaw. Despite the fact that Raw and sGaw did not add significant information in that study, these parameters did show a higher sensitivity than FEV1 and FVC to predict bronchodilator responses. Nevertheless, more recent studies suggest that these parameters can in fact accurately predict FEV1 reversibility, but these have been carried out mostly among children and adolescent populations.<a href="#bib41" class="elsevierStyleCrossRefs">16</a>, <a href="#bib49" class="elsevierStyleCrossRefs">24</a> However, one particular study showed that sGaw and FEF25–75% were the most sensitive pulmonary function measurements to detect bronchodilatation among mild asthmatic patients but these results could not be confirmed in patients with moderate disease.<a href="#bib50" class="elsevierStyleCrossRefs">25</a> Conversely, in our study, both these parameters, particularly sGaw, were able to demonstrate bronchodilator reversibility despite the fact that most of our patients had moderate asthma (FEV1 <80% of predicted).Regarding PEF, other authors also reported that reversibility of airflow obstruction in patients with obstructive lung diseases could be shown by PEF measurements in a comparable way to those obtained by FEV1.<a href="#bib40" class="elsevierStyleCrossRefs">15</a>In our study, FEF25–75% significantly contributed to the assessment of reversibility of airways in asthmatic patients. However, caution should be taken when considering FEF25–75% alone; it only should be contemplated when accompanied by an improvement in FEV1 and/or FVC, and also, the measurement should be done isovolumetrically.Our study has a number of strengths and limitations. All patients were never-smokers diagnosed with asthma based on clinical grounds; they probably were representative of a typical population of asthmatic patients. Both groups were demographically homogeneous thus avoiding possible bias. Nevertheless, our cohort is number limited and larger samples would be necessary to draw additional conclusions. Another important limitation is the lack of a control group represented by normal subjects without asthma.<a name="sec0060" class="elsevierStyleCrossRefs"></a>ConclusionsAssessment of reversibility is part of the common evaluation of patients with asthma or other obstructive pulmonary diseases, however international criteria may underestimate significant functional responses to bronchodilators in asthmatic patients. Based on our results, attention should be given to other functional parameters but the mainstream of bronchodilator treatment should not obviate the symptomatic improvements reported by each patient.<a name="sec0065" class="elsevierStyleCrossRefs"></a>Ethical disclosures<a name="sec0070" class="elsevierStyleCrossRefs"></a>Protection of human and animal subjectsThe authors declare that no experiments were performed on humans or animals for this study.<a name="sec0075" class="elsevierStyleCrossRefs"></a>Confidentiality of dataThe authors declare that they have followed the protocols of their work center on the publication of patient data.<a name="sec0080" class="elsevierStyleCrossRefs"></a>Right to privacy and informed consentThe authors declare that no patient data appear in this article.<a name="sec0085" class="elsevierStyleCrossRefs"></a>Conflicts of interestThe authors have no conflicts of interest to declare.Received 12 May 2014 Accepted 5 August 2014 Corresponding author. anafilomena@hotmail.com" "pdfFichero" => "320v21n02a90393305pdf001.pdf" "tienePdf" => true "PalabrasClave" => array:1 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec640992" "palabras" => array:4 [ 0 => "Asthma" 1 => "Pulmonary function tests" 2 => "Reversibility" 3 => "Obstruction" ] ] ] ] "tieneResumen" => true "resumen" => array:1 [ "en" => array:1 [ "resumen" => "Introduction International guidelines define significant bronchodilator response as absolute and percentage change from baseline in forced expiratory volume (FEV1) in the first second and/or forced vital capacity (FVC) ≥12% and 200 mL. However, bronchodilator effects on other lung function parameters have also been correlated to some degree of reversible airflow limitation.Objectives To determine whether changes in other lung function parameters apart from FEV1 and FVC detect functional responses to bronchodilator in asthmatic patients.Materials and methods Spirometry and body plethysmography were performed at baseline conditions and after administration of 400 μg of salbutamol by metered-dose inhaler through a space chamber device in asthmatic patients. Paired t-tests were used to compare lung function parameters between those with and without criteria for reversibility of airway obstruction according to ATS/ERS criteria. Cut-off values were obtained from the corresponding ROC curves. Measurements evaluated were FEV1, FVC, maximum mid-forced expiratory flow (FEF25–75%), residual volume (RV), inspiratory capacity (IC), airway resistance (Raw) and specific airway conductance (sGaw).Results From a total of 100 consecutive asthmatics patients (46% of them men; average age 58.7 ± 14.1 years; 76% with mild to moderate obstruction), 50 patients had a significant bronchodilator response. All of these had noteworthy variations (p < 0.004) in PEF, FEF25–75%, RV, Raw and sGaw. The most accurate in predicting a significant bronchodilator response were the absolute and percentage improvements in PEF (≥0.4 L/s and 8%), FEF25–75% (≥0.087 L/s and 27%) and the percentage of sGaw compared with that at baseline (≥25%). Based on these cut-off values, a sizeable number of the patients defined as non-responders had important changes in airway caliber. 17 patients had significant increments in the percentage of PEF and 10 had changes in absolute volume; 6 patients had increments in percentage and 16 in absolute change of FEF25–75%; 22 patients had increments in the percentage change of sGaw.Conclusions Changes of FEV1 and/or FVC may underestimate significant functional response to bronchodilators in asthmatic patients with airway obstruction when considering the change in other lung function parameters." ] ] "multimedia" => array:4 [ 0 => array:8 [ "identificador" => "fig1" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "figura" => array:1 [ 0 => array:4 [ "imagen" => "320v21n02-90393305fig1.jpg" "Alto" => 2638 "Ancho" => 2546 "Tamanyo" => 666320 ] ] "descripcion" => array:1 [ "en" => "Receiver operating characteristic (ROC) curves were used to assess alternative pulmonary function tests variables that could define a positive bronchodilator response in a population of asthmatic patients. The area under the ROC curve (AUC) was significant (>0.070) for the following criteria: percentage change of PEF, FEF 25¿75% and sGaw; and absolute change of PEF and FEF 25¿75%. Cutt-off values were attained from the exact curve speck were sensitivity and specificity reached the best correlation: absolute PEF change ¿0.4 L/s; percentage PEF change ¿8%; absolute FEF 25¿75% change ¿0.087 L/s; percentage FEF 25¿75% change ¿27%; and percentage sGaw change ¿25%. PEF: peak expiratory flow; FEF 25¿75%: maximum mid-forced expiratory flow; IC: inspiratory capacity; Raw: airway resistance; sGaw: specific airway conductance." ] ] 1 => array:8 [ "identificador" => "fig2" "etiqueta" => "Figure 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "figura" => array:1 [ 0 => array:4 [ "imagen" => "320v21n02-90393305fig2.jpg" "Alto" => 1065 "Ancho" => 1665 "Tamanyo" => 175700 ] ] "descripcion" => array:1 [ "en" => "Alternative lung function criteria for assessing bronchodilatation in a population of asthmatic patients classified as negative bronchodilators according to ATS/ERS criteria. Patients without bronchodilatation according to ATS/ERS criteria ( n = 50) were considered as positive bronchodilators according to new lung function criteria. A total of 36 patients (72%) had at least one positive criteria; 22 patients (44%) had a percentage change of sGaw ¿25%; 17 patients (34%) had a percentage change of PEF ¿8%; 16 patients (32%) had an absolute change of FEF 25¿75% ¿0.087 L/s; 10 patients (20%) had an absolute change of PEF ¿0.4 L/s; and 6 patients (12%) had a percentage change of FEF 25¿75% ¿27%. PEF: peak expiratory flow; FEF 25¿75%: maximum mid-forced expiratory flow; IC: inspiratory capacity; Raw: airway resistance; sGaw: specific airway conductance." ] ] 2 => array:5 [ "identificador" => "fig3" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" ] 3 => array:5 [ "identificador" => "fig4" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" ] ] "bibliografia" => array:2 [ "titulo" => "Bibliography" "seccion" => array:1 [ 0 => array:1 [ "bibliografiaReferencia" => array:25 [ 0 => array:3 [ "identificador" => "bib26" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Lung mechanics during induced bronchoconstriction. J Appl Physiol. 1996; 81:964-75. " "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Lung mechanics during induced bronchoconstriction." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "Pellegrino R" 1 => "Wilson O" 2 => "Jenouri G" 3 => "Rodarte JR." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ "tituloSerie" => "J Appl Physiol. " "fecha" => "1996" "volumen" => "81:964-75." ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib27" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "GINA report, Global strategy for asthma management and prevention | documents/resources | GINA. Available at: http://www.ginasthma.org/documents/4. " "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "GINA report, Global strategy for asthma management and prevention | documents/resources | GINA. Available at: http://www.ginasthma." "idioma" => "en" ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:1 [ "tituloSerie" => "org/documents/4. " ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib28" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Interpretative strategies for lung function tests. Eur Respir J. 2005; 26:948-68. " "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Interpretative strategies for lung function tests." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "Pellegrino R" 1 => "Viegi G" 2 => "Brusasco V" 3 => "Crapo RO" 4 => "Burgos F" 5 => "Casaburi R" 6 => "et-al." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "tituloSerie" => "Eur Respir J. " "fecha" => "2005" "volumen" => "26:948-68." "itemHostRev" => array:3 [ "pii" => "S0091674909009853" "estado" => "S300" "issn" => "00916749" ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib29" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "British guideline on the management of asthma. Thorax. 2003; 58(Suppl. 1):i1-i94. " "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "British guideline on the management of asthma." "idioma" => "en" ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ "tituloSerie" => "Thorax. " "fecha" => "2003" "volumen" => "58" ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib30" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Assessing the reversibility of airway obstruction. Chest. 1998; 114:1607-12. " "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Assessing the reversibility of airway obstruction." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "Pellegrino R" 1 => "Rodarte JR" 2 => "Brusasco V." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ "tituloSerie" => "Chest. " "fecha" => "1998" "volumen" => "114:1607-12." ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib31" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl. 1993; 16:5-40. " "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "Quanjer PH" 1 => "Tammeling GJ" 2 => "Cotes JE" 3 => "Pedersen OF" 4 => "Peslin R" 5 => "Yernault JC." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ "tituloSerie" => "Eur Respir J Suppl. " "fecha" => "1993" "volumen" => "16:5-40." ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib32" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Lung hyperinflation and flow limitation in chronic airway obstruction. Eur Respir J. 1997; 10:543-9. " "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Lung hyperinflation and flow limitation in chronic airway obstruction." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "Pellegrino R" 1 => "Brusasco V." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ "tituloSerie" => "Eur Respir J. " "fecha" => "1997" "volumen" => "10:543-9." ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib33" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Partial flow-volume curves to measure bronchodilator dose–response curves in normal humans. J Appl Physiol. 1981; 50:1193-7. " "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Partial flow-volume curves to measure bronchodilator dose–response curves in normal humans." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "Barnes PJ" 1 => "Gribbin HR" 2 => "Osmanliev D" 3 => "Pride NB." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ "tituloSerie" => "J Appl Physiol. " "fecha" => "1981" "volumen" => "50:1193-7." ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib34" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Effects of increasing doses of beta-agonists on airway and parenchymal hysteresis. J Appl Physiol. 1990; 68:363-8. " "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Effects of increasing doses of beta-agonists on airway and parenchymal hysteresis." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "Wang YT" 1 => "Thompson LM" 2 => "Ingenito EP" 3 => "Ingram RH." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ "tituloSerie" => "J Appl Physiol. " "fecha" => "1990" "volumen" => "68:363-8." ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib35" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Partial and maximal expiratory flow-volume curves in normal and asthmatic subjects before and after inhalation of metaproterenol. Chest. 1985; 88:697-702. " "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Partial and maximal expiratory flow-volume curves in normal and asthmatic subjects before and after inhalation of metaproterenol." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "Berry RB" 1 => "Fairshter RD." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ "tituloSerie" => "Chest. " "fecha" => "1985" "volumen" => "88:697-702." ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib36" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Assessment of bronchodilator efficacy in symptomatic COPD: is spirometry useful?. Chest. 2000; 117:42S-7S. " "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Assessment of bronchodilator efficacy in symptomatic COPD: is spirometry useful?." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "O’Donnell DE." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ "tituloSerie" => "Chest. " "fecha" => "2000" "volumen" => "117:42S-7S." ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib37" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Diagnostic accuracy of the bronchodilator response in children. J Allergy Clin Immunol. 2013; 132:. 554-559.e5. " "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Diagnostic accuracy of the bronchodilator response in children." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "Tse SM" 1 => "Gold DR" 2 => "Sordillo JE" 3 => "Hoffman EB" 4 => "Gillman MW" 5 => "Rifas-Shiman SL" 6 => "et-al." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ "tituloSerie" => "J Allergy Clin Immunol. " "fecha" => "2013" "volumen" => "132:. 554-559.e5" ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib38" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Measures of reversibility in response to bronchodilators in chronic airflow obstruction: relation to airway calibre. Thorax. 1991; 46:43-5. " "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Measures of reversibility in response to bronchodilators in chronic airflow obstruction: relation to airway calibre." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "Weir DC" 1 => "Sherwood Burge P." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ "tituloSerie" => "Thorax. " "fecha" => "1991" "volumen" => "46:43-5." ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib39" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Short term variability in FEV1 and bronchodilator responsiveness in patients with obstructive ventilatory defects. Thorax. 1987; 42:487-90. " "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Short term variability in FEV1 and bronchodilator responsiveness in patients with obstructive ventilatory defects." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "Tweeddale PM" 1 => "Alexander F" 2 => "McHardy GJ." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "tituloSerie" => "Thorax. " "fecha" => "1987" "volumen" => "42:487-90." "itemHostRev" => array:3 [ "pii" => "S1470204513703814" "estado" => "S300" "issn" => "14702045" ] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib40" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Validity of peak expiratory flow measurement in assessing reversibility of airflow obstruction. Thorax. 1992; 47:162-6. " "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Validity of peak expiratory flow measurement in assessing reversibility of airflow obstruction." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "Dekker FW" 1 => "Schrier AC" 2 => "Sterk PJ" 3 => "Dijkman JH." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ "tituloSerie" => "Thorax. " "fecha" => "1992" "volumen" => "47:162-6." ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib41" "etiqueta" => "16" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Use of specific airway resistance to assess bronchodilator response in children. Respirology. 2011; 16:666-71. " "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Use of specific airway resistance to assess bronchodilator response in children." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "Mahut B" 1 => "Peiffer C" 2 => "Bokov P" 3 => "Delclaux C" 4 => "Beydon N." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ "tituloSerie" => "Respirology. " "fecha" => "2011" "volumen" => "16:666-71." ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib42" "etiqueta" => "17" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Plethysmographic measurements of specific airway resistance in young children. Chest J. 2005; 128:355. " "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Plethysmographic measurements of specific airway resistance in young children." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "Bisgaard H." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ "tituloSerie" => "Chest J. " "fecha" => "2005" "volumen" => "128:355." ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib43" "etiqueta" => "18" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Standardisation of spirometry. Eur Respir J. 2005; 26:319-38. " "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Standardisation of spirometry." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "Miller MR" 1 => "et-al." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ "tituloSerie" => "Eur Respir J. " "fecha" => "2005" "volumen" => "26:319-38." ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib44" "etiqueta" => "19" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Standardisation of the measurement of lung volumes. Eur Respir J. 2005; 26:511-22. " "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Standardisation of the measurement of lung volumes." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "Wanger J" 1 => "Clausen JL" 2 => "Coates A" 3 => "Pedersen OF" 4 => "Brusasco V" 5 => "Burgos F" 6 => "et-al." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ "tituloSerie" => "Eur Respir J. " "fecha" => "2005" "volumen" => "26:511-22." ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib45" "etiqueta" => "20" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Lung deposition of hydrofluoroalkane-134a beclomethasone is greater than that of chlorofluorocarbon fluticasone and chlorofluorocarbon beclomethasone: a cross-over study in healthy volunteers. Chest. 2002; 122:510-6. " "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Lung deposition of hydrofluoroalkane-134a beclomethasone is greater than that of chlorofluorocarbon fluticasone and chlorofluorocarbon beclomethasone: a cross-over study in healthy volunteers." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "Leach CL" 1 => "Davidson PJ" 2 => "Hasselquist BE" 3 => "Boudreau RJ." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ "tituloSerie" => "Chest. " "fecha" => "2002" "volumen" => "122:510-6." ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib46" "etiqueta" => "21" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Effect of size and disease on estimated deposition of drugs administered using jet nebulization in children with cystic fibrosis. Chest. 2001; 119:1123-30. " "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Effect of size and disease on estimated deposition of drugs administered using jet nebulization in children with cystic fibrosis." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "Coates AL" 1 => "Allen PD" 2 => "MacNeish CF" 3 => "Ho SL" 4 => "Lands LC." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ "tituloSerie" => "Chest. " "fecha" => "2001" "volumen" => "119:1123-30." ] ] ] ] ] ] 21 => array:3 [ "identificador" => "bib47" "etiqueta" => "22" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Acute response to bronchodilator. An imperfect guide for bronchodilator therapy in chronic airflow limitation. Arch Intern Med. 1988; 148:1949-52. " "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Acute response to bronchodilator. An imperfect guide for bronchodilator therapy in chronic airflow limitation." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "Guyatt GH" 1 => "Townsend M" 2 => "Nogradi S" 3 => "Pugsley SO" 4 => "Keller JL" 5 => "Newhouse MT." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ "tituloSerie" => "Arch Intern Med. " "fecha" => "1988" "volumen" => "148:1949-52." ] ] ] ] ] ] 22 => array:3 [ "identificador" => "bib48" "etiqueta" => "23" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "The one best test for evaluating the effects of bronchodilator therapy. Chest. 1977; 72:512-6. " "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "The one best test for evaluating the effects of bronchodilator therapy." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "Light RW" 1 => "Conrad SA" 2 => "George RB." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ "tituloSerie" => "Chest. " "fecha" => "1977" "volumen" => "72:512-6." ] ] ] ] ] ] 23 => array:3 [ "identificador" => "bib49" "etiqueta" => "24" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Evaluation of the magnitude of the bronchodilator response in children and adolescents with asthma. Chest. 2005; 127:530-5. " "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "Evaluation of the magnitude of the bronchodilator response in children and adolescents with asthma." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "Bussamra MH" 1 => "Cukier A" 2 => "Stelmach R" 3 => "Rodrigues JC." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ "tituloSerie" => "Chest. " "fecha" => "2005" "volumen" => "127:530-5." ] ] ] ] ] ] 24 => array:3 [ "identificador" => "bib50" "etiqueta" => "25" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "A comparison of lung function methods for assessing dose–response effects of salbutamol. Br J Clin Pharmacol. 2004; 58:134-41. " "contribucion" => array:1 [ 0 => array:3 [ "titulo" => "A comparison of lung function methods for assessing dose–response effects of salbutamol." "idioma" => "en" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "Houghton CM" 1 => "Woodcock AA" 2 => "Singh D." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ "tituloSerie" => "Br J Clin Pharmacol. " "fecha" => "2004" "volumen" => "58:134-41." ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/08732159/0000002100000002/v0_201604141148/X087321591593305X/v0_201604141148/en/main.assets" "Apartado" => array:4 [ "identificador" => "18133" "tipo" => "SECCION" "es" => array:2 [ "titulo" => "Artigos originais" "idiomaDefecto" => true ] "idiomaDefecto" => "es" ] "PDF" => "https://static.elsevier.es/multimedia/08732159/0000002100000002/v0_201604141148/X087321591593305X/v0_201604141148/en/320v21n02a90393305pdf001.pdf?idApp=UINPBA00004E&text.app=https://journalpulmonology.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X087321591593305X?idApp=UINPBA00004E"]

Statistics

A.. Tavares e Castroa,

Corresponding author

anafilomena@hotmail.com

Corresponding author. anafilomena@hotmail.com

, P.. Matosa, B.. Tavaresb, M.J.. Matosa, A.. Segorbe-Luísb

a Pulmonology Unit, Hospitais da Universidade de Coimbra, Centro Hospitalar Universitário de Coimbra, Coimbra, Portugal

b Immunoallergology Unit, Hospitais da Universidade de Coimbra, Centro Hospitalar Universitário de Coimbra, Coimbra, Portugal

Read

11484

Times
was read the article

3225

Total PDF

8259

Total HTML

Share statistics

 array:20 [
  "pii" => "X087321591593305X"
  "issn" => "08732159"
  "doi" => "10.1016/j.rppnen.2014.08.002"
  "estado" => "S300"
  "fechaPublicacion" => "2015-03-01"
  "documento" => "article"
  "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
  "subdocumento" => "fla"
  "cita" => "Rev Port Pneumol. 2015;21:69-75"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 4901
    "formatos" => array:3 [
      "EPUB" => 250
      "HTML" => 3496
      "PDF" => 1155
    ]
  ]
  "itemSiguiente" => array:16 [
    "pii" => "X0873215915933068"
    "issn" => "08732159"
    "doi" => "10.1016/j.rppnen.2014.05.005"
    "estado" => "S300"
    "fechaPublicacion" => "2015-03-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Rev Port Pneumol. 2015;21:76-81"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 14072
      "formatos" => array:3 [
        "EPUB" => 301
        "HTML" => 11081
        "PDF" => 2690
      ]
    ]
    "en" => array:11 [
      "idiomaDefecto" => true
      "titulo" => "Inspiratory muscle training with threshold or incentive spirometry&#58; Which is the most effective&#63;"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "76"
          "paginaFinal" => "81"
        ]
      ]
      "contieneResumen" => array:1 [
        "en" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:8 [
          "identificador" => "fig1"
          "etiqueta" => "Figure 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "copyright" => "Elsevier Espa&#241;a"
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "320v21n02-90393306fig1.jpg"
              "Alto" => 965
              "Ancho" => 1558
              "Tamanyo" => 125668
            ]
          ]
          "descripcion" => array:1 [
            "en" => "Effects of inspiratory muscular training in groups studied&#46; Comparison between pre-IMT at 15 days in threshold group &#191; TG &#40;&#42; <span class="elsevierStyleItalic">p</span>&#160;&#60;&#160;0&#46;001&#41; and incentive spirometry group &#191; ISG &#40;&#42; <span class="elsevierStyleItalic">p</span>&#160;&#60;&#160;0&#46;001&#41;&#44; and at 30 days in TG &#40;&#42;&#42; <span class="elsevierStyleItalic">p</span>&#160;&#60;&#160;0&#46;001&#41; and ISG &#40;&#42;&#42; <span class="elsevierStyleItalic">p</span>&#160;&#60;&#160;0&#46;001&#41;&#46; Comparison between the three groups in pre-IMT &#40; <span class="elsevierStyleSup">&#35;</span> <span class="elsevierStyleItalic">p</span>&#160;&#61;&#160;0&#46;494&#41;&#44; 15 days &#40; <span class="elsevierStyleSup">&#35;&#35;</span> <span class="elsevierStyleItalic">p</span>&#160;&#60;&#160;0&#46;001&#41; and 30 days &#40; <span class="elsevierStyleSup">&#35;&#35;&#35;</span> <span class="elsevierStyleItalic">p</span>&#160;&#60;&#160;0&#46;001&#41; conditions&#46; Difference between the TG and ISG at 15 days &#40; <span class="elsevierStyleSup">&#43;</span> <span class="elsevierStyleItalic">p</span>&#160;&#61;&#160;0&#46;328&#41; and at 30 days &#40; <span class="elsevierStyleSup">&#43;&#43;</span> <span class="elsevierStyleItalic">p</span>&#160;&#61;&#160;0&#46;045&#41;&#46; CG&#58; control group&#59; TG&#58; threshold group&#59; ISG&#58; incentive spirometry group&#46; ANOVA two-way test followed by Bonferroni multiple comparison&#46; Significance was accepted at <span class="elsevierStyleItalic">p</span>&#160;&#60;&#160;0&#46;05&#46;"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Dulciane Nunes Paiva, La&#237;se Bender Assmann, Diogo Fanfa Bordin, Ricardo Gass, Renan Trevisan Jost, Mario Bernardo-Filho, Rodrigo Alves Fran&#231;a, Dannuey Machado Cardoso"
          "autores" => array:8 [
            0 => array:2 [
              "nombre" => "Dulciane Nunes"
              "apellidos" => "Paiva"
            ]
            1 => array:2 [
              "nombre" => "La&#237;se Bender"
              "apellidos" => "Assmann"
            ]
            2 => array:2 [
              "nombre" => "Diogo Fanfa"
              "apellidos" => "Bordin"
            ]
            3 => array:2 [
              "nombre" => "Ricardo"
              "apellidos" => "Gass"
            ]
            4 => array:2 [
              "nombre" => "Renan Trevisan"
              "apellidos" => "Jost"
            ]
            5 => array:2 [
              "nombre" => "Mario"
              "apellidos" => "Bernardo-Filho"
            ]
            6 => array:2 [
              "nombre" => "Rodrigo Alves"
              "apellidos" => "Fran&#231;a"
            ]
            7 => array:2 [
              "nombre" => "Dannuey Machado"
              "apellidos" => "Cardoso"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0873215915933068?idApp=UINPBA00004E"
    "url" => "/08732159/0000002100000002/v0_201604141148/X0873215915933068/v0_201604141148/en/main.assets"
  ]
  "itemAnterior" => array:16 [
    "pii" => "X0873215915933041"
    "issn" => "08732159"
    "doi" => "10.1016/j.rppnen.2014.04.009"
    "estado" => "S300"
    "fechaPublicacion" => "2015-03-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Rev Port Pneumol. 2015;21:61-8"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 8278
      "formatos" => array:3 [
        "EPUB" => 275
        "HTML" => 5851
        "PDF" => 2152
      ]
    ]
    "en" => array:11 [
      "idiomaDefecto" => true
      "titulo" => "Validation of a Portuguese version of the STOP-Bang questionnaire as a screening tool for obstructive sleep apnea&#58; Analysis in a sleep clinic"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "61"
          "paginaFinal" => "68"
        ]
      ]
      "contieneResumen" => array:1 [
        "en" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:8 [
          "identificador" => "fig1"
          "etiqueta" => "Figure 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "copyright" => "Elsevier Espa&#241;a"
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "320v21n02-90393304fig1.jpg"
              "Alto" => 977
              "Ancho" => 1505
              "Tamanyo" => 95319
            ]
          ]
          "descripcion" => array:1 [
            "en" => "Distribution of patients according to their STOP-Bang score&#46;"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "R. Reis, F. Teixeira, V. Martins, L. Sousa, L. Batata, C. Santos, J. Moutinho"
          "autores" => array:7 [
            0 => array:2 [
              "Iniciales" => "R."
              "apellidos" => "Reis"
            ]
            1 => array:2 [
              "Iniciales" => "F."
              "apellidos" => "Teixeira"
            ]
            2 => array:2 [
              "Iniciales" => "V."
              "apellidos" => "Martins"
            ]
            3 => array:2 [
              "Iniciales" => "L."
              "apellidos" => "Sousa"
            ]
            4 => array:2 [
              "Iniciales" => "L."
              "apellidos" => "Batata"
            ]
            5 => array:2 [
              "Iniciales" => "C."
              "apellidos" => "Santos"
            ]
            6 => array:2 [
              "Iniciales" => "J."
              "apellidos" => "Moutinho"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0873215915933041?idApp=UINPBA00004E"
    "url" => "/08732159/0000002100000002/v0_201604141148/X0873215915933041/v0_201604141148/en/main.assets"
  ]
  "en" => array:14 [
    "idiomaDefecto" => true
    "titulo" => "Alternative functional criteria to assess airflow-limitation reversibility in asthma"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "69"
        "paginaFinal" => "75"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "A. Tavares e Castro, P. Matos, B. Tavares, M.J. Matos, A. Segorbe-Lu&#237;s"
        "autores" => array:5 [
          0 => array:4 [
            "Iniciales" => "A."
            "apellidos" => "Tavares e Castro"
            "email" => array:1 [
              0 => "anafilomena&#64;hotmail&#46;com"
            ]
            "referencia" => array:2 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "affa"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor1"
              ]
            ]
          ]
          1 => array:3 [
            "Iniciales" => "P."
            "apellidos" => "Matos"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "affa"
              ]
            ]
          ]
          2 => array:3 [
            "Iniciales" => "B."
            "apellidos" => "Tavares"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "affb"
              ]
            ]
          ]
          3 => array:3 [
            "Iniciales" => "M.J."
            "apellidos" => "Matos"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "affa"
              ]
            ]
          ]
          4 => array:3 [
            "Iniciales" => "A."
            "apellidos" => "Segorbe-Lu&#237;s"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "affb"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:2 [
          0 => array:3 [
            "entidad" => "Pulmonology Unit, Hospitais da Universidade de Coimbra, Centro Hospitalar Universitário de Coimbra, Coimbra, Portugal"
            "etiqueta" => "<span class="elsevierStyleSup">a</span>"
            "identificador" => "affa"
          ]
          1 => array:3 [
            "entidad" => "Immunoallergology Unit, Hospitais da Universidade de Coimbra, Centro Hospitalar Universitário de Coimbra, Coimbra, Portugal"
            "etiqueta" => "<span class="elsevierStyleSup">b</span>"
            "identificador" => "affb"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor1"
            "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
            "correspondencia" => "Corresponding author. anafilomena@hotmail.com"
          ]
        ]
      ]
    ]
    "resumenGrafico" => array:2 [
      "original" => 0
      "multimedia" => array:8 [
        "identificador" => "fig1"
        "etiqueta" => "Figure 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "copyright" => "Elsevier Espa&#241;a"
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "320v21n02-90393305fig1.jpg"
            "Alto" => 2638
            "Ancho" => 2546
            "Tamanyo" => 666320
          ]
        ]
        "descripcion" => array:1 [
          "en" => "Receiver operating characteristic &#40;ROC&#41; curves were used to assess alternative pulmonary function tests variables that could define a positive bronchodilator response in a population of asthmatic patients&#46; The area under the ROC curve &#40;AUC&#41; was significant &#40;&#62;0&#46;070&#41; for the following criteria&#58; percentage change of PEF&#44; FEF <span class="elsevierStyleInf">25&#191;75&#37;</span> and sGaw&#59; and absolute change of PEF and FEF <span class="elsevierStyleInf">25&#191;75&#37;</span>&#46; Cutt-off values were attained from the exact curve speck were sensitivity and specificity reached the best correlation&#58; absolute PEF change &#191;0&#46;4&#160;L&#47;s&#59; percentage PEF change &#191;8&#37;&#59; absolute FEF <span class="elsevierStyleInf">25&#191;75&#37;</span> change &#191;0&#46;087&#160;L&#47;s&#59; percentage FEF <span class="elsevierStyleInf">25&#191;75&#37;</span> change &#191;27&#37;&#59; and percentage sGaw change &#191;25&#37;&#46; PEF&#58; peak expiratory flow&#59; FEF <span class="elsevierStyleInf">25&#191;75&#37;</span>&#58; maximum mid-forced expiratory flow&#59; IC&#58; inspiratory capacity&#59; Raw&#58; airway resistance&#59; sGaw&#58; specific airway conductance&#46;"
        ]
      ]
    ]
    "textoCompleto" => "<a name="sec0005" class="elsevierStyleCrossRefs"></a><span class="elsevierStyleSectionTitle">Introduction</span><p class="elsevierStylePara">Airway obstruction reversibility&#44; evaluated by the bronchodilator response&#44; is routinely assessed to assist and support the diagnosis of asthma&#46;<a href="&#35;bib26" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">1</span></a><span class="elsevierStyleSup">&#44; </span><a href="&#35;bib27" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">2</span></a> The most recent guidelines published by the American Thoracic Society and the European Respiratory Society &#40;ATS&#47;ERS&#41; in 2005 on reversibility testing define significant bronchodilator response as a 12&#37; per cent increase from baseline and a 200&#160;mL absolute increase in forced expiratory volume in 1&#160;s &#40;FEV<span class="elsevierStyleInf">1</span>&#41; and&#47;or forced vital capacity &#40;FVC&#41;&#46;<a href="&#35;bib28" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">3</span></a></p><p class="elsevierStylePara">However&#44; there is considerable variation within the guidelines as to the degree of reversibility considered significant&#46; The British Thoracic Society&#44;<a href="&#35;bib29" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">4</span></a> for example&#44; recommends at least 15&#37; increase of baseline FEV<span class="elsevierStyleInf">1</span> while the Global Initiative for Asthma &#40;GINA&#41;<a href="&#35;bib27" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">2</span></a> recommends at least 12&#37; of baseline FEV<span class="elsevierStyleInf">1</span> for the bronchodilator response to be considered positive&#46;</p><p class="elsevierStylePara">Airway obstruction reversibility is still a controversial topic also because there is still a lack of consensus on which variables should be used to express bronchodilator response&#46; In fact&#44; despite the general use of FEV<span class="elsevierStyleInf">1</span> or FVC criteria&#44; some studies have concluded that changes in these measurements can frequently underestimate significant responses to bronchodilator in both adults and children&#46;<a href="&#35;bib30" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">5</span></a><span class="elsevierStyleSup">&#44; </span><a href="&#35;bib31" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">6</span></a><span class="elsevierStyleSup">&#44; </span><a href="&#35;bib32" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">7</span></a><span class="elsevierStyleSup">&#44; </span><a href="&#35;bib33" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">8</span></a><span class="elsevierStyleSup">&#44; </span><a href="&#35;bib34" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">9</span></a><span class="elsevierStyleSup">&#44; </span><a href="&#35;bib35" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">10</span></a><span class="elsevierStyleSup">&#44; </span><a href="&#35;bib36" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">11</span></a><span class="elsevierStyleSup">&#44; </span><a href="&#35;bib37" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">12</span></a></p><p class="elsevierStylePara">On the other hand&#44; when reversibility is expressed by the percentage increase in FEV<span class="elsevierStyleInf">1</span>&#44; it shows bronchodilator responses more frequently in the most severely obstructed patients&#46;<a href="&#35;bib38" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">13</span></a><span class="elsevierStyleSup">&#44; </span><a href="&#35;bib39" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">14</span></a></p><p class="elsevierStylePara">Also&#44; when changes in FEV<span class="elsevierStyleInf">1</span> are not meaningful&#44; alternative criteria such as decrease in lung hyperinflation&#44; can establish a substantial response&#46;<a href="&#35;bib28" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">3</span></a><span class="elsevierStyleSup">&#44; </span><a href="&#35;bib30" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">5</span></a><span class="elsevierStyleSup">&#44; </span><a href="&#35;bib32" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">7</span></a> In the same way&#44; absolute changes in peak expiratory flow &#40;PEF&#41; have proved to be a good substitute to establish airway obstruction reversibility in asthma&#46;<a href="&#35;bib40" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">15</span></a></p><p class="elsevierStylePara">Difficulties in performing a forced expiratory maneuver may further limit use of FEV<span class="elsevierStyleInf">1</span> or FVC&#44; particularly in children and older patients&#46; In these cases&#44; criteria such as airway resistance &#40;Raw&#41; or specific airway conductance &#40;sGaw&#41; may be useful&#46;<a href="&#35;bib41" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">16</span></a><span class="elsevierStyleSup">&#44; </span><a href="&#35;bib42" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">17</span></a></p><p class="elsevierStylePara">Assuming that the significant changes in other ventilatory parameters can explain the bronchodilator improvement of dyspnea even without significant changes in FEV<span class="elsevierStyleInf">1</span> and&#47;or FVC&#44; we performed the present study to investigate alternative criteria of positivity in a population of asthmatic patients with documented airway obstruction&#46; Baseline and post-bronchodilator spirometry and body plethysmography were performed on all patients&#46; Unusual pulmonary function variables &#8211; PEF&#44; maximum mid-forced expiratory flow &#40;FEF<span class="elsevierStyleInf">25&#8211;75&#37;</span>&#41;&#44; total lung capacity &#40;TLC&#41;&#44; residual volume &#40;RV&#41;&#44; inspiratory capacity &#40;IC&#41;&#44; Raw and sGaw &#8211; which could possibly assess bronchodilator response were retrospectively collected and analyzed&#46;</p><a name="sec0010" class="elsevierStyleCrossRefs"></a><span class="elsevierStyleSectionTitle">Methods</span><a name="sec0015" class="elsevierStyleCrossRefs"></a><span class="elsevierStyleSectionTitle">Subjects</span><p class="elsevierStylePara">One hundred never-smoker asthmatic patients referred to our Pulmonary Physiology Laboratory by their immunoallergology or pulmonology physician were included in the present study&#46; This population included two matched groups of 50 consecutive patients with and without a significant bronchodilator response defined according to the 2005 ATS&#47;ERS guidelines&#46; Patients under 20 years old&#44; smokers&#44; with severe asthma&#44; recent asthma acute exacerbations or cardiovascular disease&#44; were excluded&#46;</p><a name="sec0020" class="elsevierStyleCrossRefs"></a><span class="elsevierStyleSectionTitle">Lung function measurements</span><p class="elsevierStylePara">Spirometric measurements were made using a pneumotachograph &#40;MasterScreen PTF Ja&#235;ger<span class="elsevierStyleSup">&#174;</span>&#41;&#46; Plethysmography measurements were obtained through a body plethysmograph &#40;MasterScreen Body Ja&#235;ger<span class="elsevierStyleSup">&#174;</span>&#41;&#46; All spirometric and plethysmographic tests were performed according to accepted standards as recommended by the ATS&#46;<a href="&#35;bib43" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">18</span></a><span class="elsevierStyleSup">&#44; </span><a href="&#35;bib44" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">19</span></a></p><a name="sec0025" class="elsevierStyleCrossRefs"></a><span class="elsevierStyleSectionTitle">Reversibility testing</span><p class="elsevierStylePara">All medication likely to interfere with bronchomotricity was previously suspended&#46;<a href="&#35;bib43" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">18</span></a> Short- and long-acting &#946;-agonists bronchodilators were suspended 4&#160;h and 12&#160;h prior to the test&#44; respectively&#44; while oral theophylines were stopped 12&#8211;24&#160;h before&#46; Patients were instructed not to smoke and avoid food containing caffeine &#40;coffee&#44; tea&#44; cola&#41; or theobromine &#40;chocolate&#41; for at least 1&#160;h before the test&#46;</p><p class="elsevierStylePara">All patients underwent spirometric and lung volumes evaluation at baseline conditions&#46; An obstructive ventilatory defect was defined by a FEV<span class="elsevierStyleInf">1</span>&#47;FVC ratio less than 0&#46;70&#46; Only those with verified airflow obstruction and three satisfactory records of FEV<span class="elsevierStyleInf">1</span>&#44; FVC and PEF were submitted to further challenge with bronchodilator&#46; Airway-obstruction reversibility was tested 10&#160;min after administration of four equal and separate doses of 100&#160;&#956;g &#40;total dose 400&#160;&#956;g&#41; of salbutamol given by a metered-dose inhaler connected to a space chamber device&#46;<a href="&#35;bib45" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">20</span></a><span class="elsevierStyleSup">&#44; </span><a href="&#35;bib46" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">21</span></a></p><a name="sec0030" class="elsevierStyleCrossRefs"></a><span class="elsevierStyleSectionTitle">Statistical analysis</span><p class="elsevierStylePara">Data analysis was performed by IBM SPSS<span class="elsevierStyleSup">&#174;</span> for Windows version 20&#46;0&#46; All patient demographic and clinical features were reported using frequency and descriptive analyses&#46; Average and standard deviation &#40;SD&#41; scores were calculated for numerical variables&#44; and number and percent for categorical variables&#46; Pearson&#39;s chi-square and ordinary <span class="elsevierStyleItalic">t</span>-tests were used for comparison of means and proportions&#46; Two-tailed <span class="elsevierStyleItalic">p</span> values of less than 0&#46;05 were considered to indicate statistical significance&#46; Paired <span class="elsevierStyleItalic">t</span>-tests were used to compare lung function parameters between those with and without criteria for reversibility of airway obstruction according to ATS&#47;ERS criteria&#46; Cut-off values were obtained from the exact value where there was ideal matching of both sensitivity and specificity values on ROC curves&#46; Measurements evaluated were FEV<span class="elsevierStyleInf">1</span>&#44; FVC&#44; PEF&#44; FEF<span class="elsevierStyleInf">25&#8211;75&#37;</span>&#44; RV&#44; IC&#44; Raw and sGaw&#46;</p><a name="sec0035" class="elsevierStyleCrossRefs"></a><span class="elsevierStyleSectionTitle">Results</span><a name="sec0040" class="elsevierStyleCrossRefs"></a><span class="elsevierStyleSectionTitle">Demographics</span><p class="elsevierStylePara">Demographic data of the studied population are shown in <a href="&#35;t0005" class="elsevierStyleCrossRefs">Table 1</a>&#46; Compared to patients with a positive bronchodilator response&#44; patients with no airway obstruction reversibility were older &#40;62&#46;1 versus 56&#46;1 years old&#41; and predominantly female&#44; but these differences did not reach statistical significance&#46; Body mass index was basically the same between both sets of asthmatic patients&#46;</p><p class="elsevierStylePara">Table 1&#46; Demographic and lung function characteristics of patients with asthma&#46;</p><a name="t0005" class="elsevierStyleCrossRefs"></a><p class="elsevierStylePara"></p><table><tr align="left"><td>&#160;</td><td colspan="2">Reversibility of airway obstruction  <span class="elsevierStyleSup">a</span></td><td><span class="elsevierStyleItalic">p</span> value</td></tr><tr align="left"><td>&#160;</td><td>No &#40;<span class="elsevierStyleItalic">n</span>&#160;&#61;&#160;50&#41;</td><td>Yes &#40;<span class="elsevierStyleItalic">n</span>&#160;&#61;&#160;50&#41;</td><td>&#160;</td></tr><tr align="left"><td><span class="elsevierStyleItalic">Gender&#44; n &#40;&#37;&#41;</span></td><td>&#160;</td><td>&#160;</td><td>0&#46;045</td></tr><tr align="left"><td>Male</td><td>18 &#40;36&#41;</td><td>28 &#40;56&#46;0&#41;</td><td>&#160;</td></tr><tr align="left"><td>Female</td><td>32 &#40;64&#46;0&#41;</td><td>22 &#40;44&#46;0&#41;</td><td>&#160;</td></tr><tr align="left"><td colspan="4">&#160;</td></tr><tr align="left"><td><span class="elsevierStyleItalic">Age&#44; years</span></td><td>61&#46;2&#160;&#177;&#160;11&#46;9</td><td>56&#46;1&#160;&#177;&#160;15&#46;6</td><td>NS</td></tr><tr align="left"><td><span class="elsevierStyleItalic">BMI&#44; kg&#47;m</span><span class="elsevierStyleSup"><span class="elsevierStyleItalic">2</span></span></td><td>28&#46;4&#160;&#177;&#160;4&#46;6</td><td>28&#46;5&#160;&#177;&#160;5&#46;7</td><td>NS</td></tr><tr align="left"><td><span class="elsevierStyleItalic">FEV1&#47;FVC</span></td><td>0&#46;6&#160;&#177;&#160;0&#46;1</td><td>0&#46;6&#160;&#177;&#160;0&#46;1</td><td>0&#46;029</td></tr><tr align="left"><td colspan="4">&#160;</td></tr><tr align="left"><td colspan="4"><span class="elsevierStyleItalic">FVC</span></td></tr><tr align="left"><td>Baseline&#44; L</td><td>2&#46;8&#160;&#177;&#160;1&#46;0</td><td>3&#46;1&#160;&#177;&#160;1&#46;0</td><td>NS</td></tr><tr align="left"><td>Baseline&#44; &#37; of predicted</td><td>99&#46;5&#160;&#177;&#160;17&#46;9</td><td>92&#46;2&#160;&#177;&#160;16&#46;0</td><td>0&#46;033</td></tr><tr align="left"><td>Post-bronchodilator&#44; L</td><td>2&#46;8&#160;&#177;&#160;1&#46;1</td><td>3&#46;4&#160;&#177;&#160;1&#46;0</td><td>0&#46;007</td></tr><tr align="left"><td>Post-bronchodilator change&#44; L</td><td>0&#46;0&#160;&#177;&#160;0&#46;3</td><td>0&#46;3&#160;&#177;&#160;0&#46;2</td><td>0&#46;000</td></tr><tr align="left"><td>Post-bronchodilator change&#44; &#37;</td><td>1&#46;4&#160;&#177;&#160;3&#46;4</td><td>10&#46;8&#160;&#177;&#160;6&#46;2</td><td>0&#46;000</td></tr><tr align="left"><td colspan="4">&#160;</td></tr><tr align="left"><td colspan="4"><span class="elsevierStyleItalic">FEV</span><span class="elsevierStyleInf"><span class="elsevierStyleItalic">1</span></span></td></tr><tr align="left"><td>Baseline&#44; L</td><td>1&#46;8&#160;&#177;&#160;0&#46;7</td><td>1&#46;9&#160;&#177;&#160;0&#46;7</td><td>NS</td></tr><tr align="left"><td>Baseline&#44; &#37; of predicted</td><td>76&#46;2&#160;&#177;&#160;16&#46;1</td><td>67&#46;6&#160;&#177;&#160;15&#46;9</td><td>0&#46;008</td></tr><tr align="left"><td>Post-bronchodilator&#44; L</td><td>1&#46;9&#160;&#177;&#160;0&#46;7</td><td>2&#46;1&#160;&#177;&#160;0&#46;8</td><td>0&#46;044</td></tr><tr align="left"><td>Post-bronchodilator change&#44; L</td><td>0&#46;1&#160;&#177;&#160;0&#46;1</td><td>0&#46;3&#160;&#177;&#160;0&#46;2</td><td>0&#46;000</td></tr><tr align="left"><td>Post-bronchodilator change&#44; &#37;</td><td>3&#46;9&#160;&#177;&#160;5&#46;1</td><td>18&#46;5&#160;&#177;&#160;11&#46;8</td><td>0&#46;000</td></tr><tr align="left"><td colspan="4">&#160;</td></tr><tr align="left"><td colspan="4"><span class="elsevierStyleItalic">PEF</span></td></tr><tr align="left"><td>Baseline&#44; L&#47;s</td><td>4&#46;7&#160;&#177;&#160;1&#46;7</td><td>4&#46;8&#160;&#177;&#160;1&#46;6</td><td>NS</td></tr><tr align="left"><td>Baseline&#44; &#37; of predicted</td><td>73&#46;1&#160;&#177;&#160;22&#46;1</td><td>67&#46;0&#160;&#177;&#160;16&#46;7</td><td>NS</td></tr><tr align="left"><td>Post-bronchodilator&#44; L&#47;s</td><td>5&#46;0&#160;&#177;&#160;1&#46;9</td><td>5&#46;7&#160;&#177;&#160;1&#46;7</td><td>NS</td></tr><tr align="left"><td>Post-bronchodilator change&#44; L&#47;s</td><td>0&#46;3&#160;&#177;&#160;0&#46;5</td><td>0&#46;8&#160;&#177;&#160;0&#46;5</td><td>0&#46;000</td></tr><tr align="left"><td>Post-bronchodilator change&#44; &#37;</td><td>5&#46;6&#160;&#177;&#160;10&#46;9</td><td>19&#46;1&#160;&#177;&#160;12&#46;6</td><td>0&#46;000</td></tr><tr align="left"><td colspan="4">&#160;</td></tr><tr align="left"><td colspan="4"><span class="elsevierStyleItalic">FEF</span><span class="elsevierStyleInf">25&#8211;75</span><span class="elsevierStyleInf"><span class="elsevierStyleItalic">&#37;</span></span></td></tr><tr align="left"><td>Baseline&#44; L&#47;s</td><td>0&#46;8&#160;&#177;&#160;0&#46;5</td><td>0&#46;8&#160;&#177;&#160;0&#46;5</td><td>NS</td></tr><tr align="left"><td>Baseline&#44; &#37; of predicted</td><td>27&#46;6&#160;&#177;&#160;15&#46;0</td><td>23&#46;8&#160;&#177;&#160;11&#46;9</td><td>NS</td></tr><tr align="left"><td>Post-bronchodilator&#44; L&#47;s</td><td>0&#46;9&#160;&#177;&#160;0&#46;6</td><td>1&#46;1&#160;&#177;&#160;0&#46;7</td><td>NS</td></tr><tr align="left"><td>Post-bronchodilator change&#44; L&#47;s</td><td>0&#46;5&#160;&#177;&#160;0&#46;2</td><td>0&#46;3&#160;&#177;&#160;0&#46;3</td><td>0&#46;009</td></tr><tr align="left"><td>Post-bronchodilator change&#44; &#37;</td><td>5&#46;3&#160;&#177;&#160;23&#46;9</td><td>39&#46;4&#160;&#177;&#160;62&#46;6</td><td>0&#46;001</td></tr><tr align="left"><td colspan="4">&#160;</td></tr><tr align="left"><td colspan="4"><span class="elsevierStyleItalic">TLC</span></td></tr><tr align="left"><td>Baseline&#44; L</td><td>5&#46;5&#160;&#177;&#160;1&#46;3</td><td>6&#46;0&#160;&#177;&#160;1&#46;4</td><td>NS</td></tr><tr align="left"><td>Baseline&#44; &#37; of predicted</td><td>108&#46;3&#160;&#177;&#160;14&#46;3</td><td>106&#46;9&#160;&#177;&#160;14&#46;1</td><td>NS</td></tr><tr align="left"><td>Post-bronchodilator&#44; L</td><td>5&#46;5&#160;&#177;&#160;1&#46;2</td><td>6&#46;0&#160;&#177;&#160;1&#46;3</td><td>NS</td></tr><tr align="left"><td>Post-bronchodilator change&#44; L</td><td>0&#46;0&#160;&#177;&#160;0&#46;2</td><td>0&#46;0&#160;&#177;&#160;0&#46;3</td><td>NS</td></tr><tr align="left"><td>Post-bronchodilator change&#44; &#37;</td><td>0&#46;1&#160;&#177;&#160;4&#46;6</td><td>1&#46;0&#160;&#177;&#160;5&#46;4</td><td>NS</td></tr><tr align="left"><td colspan="4">&#160;</td></tr><tr align="left"><td colspan="4"><span class="elsevierStyleItalic">RV</span></td></tr><tr align="left"><td>Baseline&#44; L</td><td>3&#46;1&#160;&#177;&#160;4&#46;7</td><td>2&#46;7&#160;&#177;&#160;0&#46;8</td><td>NS</td></tr><tr align="left"><td>Baseline&#44; &#37; of predicted</td><td>122&#46;8&#160;&#177;&#160;31&#46;64</td><td>132&#46;0&#160;&#177;&#160;31&#46;70</td><td>NS</td></tr><tr align="left"><td>Post-bronchodilator&#44; L</td><td>2&#46;9&#160;&#177;&#160;3&#46;7</td><td>2&#46;4&#160;&#177;&#160;0&#46;7</td><td>NS</td></tr><tr align="left"><td>Post-bronchodilator change&#44; L</td><td>&#8722;0&#46;2&#160;&#177;&#160;1&#46;0</td><td>&#8722;0&#46;2&#160;&#177;&#160;0&#46;3</td><td>NS</td></tr><tr align="left"><td>Post-bronchodilator change&#44; &#37;</td><td>&#8722;2&#46;7&#160;&#177;&#160;10&#46;6</td><td>&#8722;7&#46;2&#160;&#177;&#160;11&#46;2</td><td>0&#46;037</td></tr><tr align="left"><td colspan="4">&#160;</td></tr><tr align="left"><td colspan="4"><span class="elsevierStyleItalic">IC</span></td></tr><tr align="left"><td>Baseline&#44; L</td><td>2&#46;5&#160;&#177;&#160;0&#46;8</td><td>2&#46;5&#160;&#177;&#160;0&#46;8</td><td>NS</td></tr><tr align="left"><td>Baseline&#44; &#37; of predicted</td><td>119&#46;6&#160;&#177;&#160;25&#46;7</td><td>102&#46;0&#160;&#177;&#160;24&#46;6</td><td>0&#46;000</td></tr><tr align="left"><td>Post-bronchodilator&#44; L</td><td>2&#46;5&#160;&#177;&#160;0&#46;8</td><td>3&#46;0&#160;&#177;&#160;1&#46;8</td><td>NS</td></tr><tr align="left"><td>Post-bronchodilator change&#44; L</td><td>0&#46;1&#160;&#177;&#160;0&#46;2</td><td>0&#46;5&#160;&#177;&#160;1&#46;8</td><td>NS</td></tr><tr align="left"><td>Post-bronchodilator change&#44; &#37;</td><td>4&#46;2&#160;&#177;&#160;9&#46;2</td><td>11&#46;2&#160;&#177;&#160;15&#46;2</td><td>0&#46;006</td></tr><tr align="left"><td colspan="4">&#160;</td></tr><tr align="left"><td colspan="4"><span class="elsevierStyleItalic">Raw</span></td></tr><tr align="left"><td>Baseline&#44; kPa&#160;s&#47;L</td><td>0&#46;5&#160;&#177;&#160;0&#46;2</td><td>0&#46;5&#160;&#177;&#160;0&#46;2</td><td>NS</td></tr><tr align="left"><td>Baseline&#44; &#37; of predicted</td><td>164&#46;8&#160;&#177;&#160;78&#46;5</td><td>170&#46;8&#160;&#177;&#160;79&#46;9</td><td>NS</td></tr><tr align="left"><td>Post-bronchodilator&#44; kPa&#160;s&#47;L</td><td>0&#46;4&#160;&#177;&#160;1&#46;2</td><td>0&#46;3&#160;&#177;&#160;0&#46;2</td><td>0&#46;000</td></tr><tr align="left"><td>Post-bronchodilator change&#44; kPa&#160;s&#47;L</td><td>&#8722;0&#46;1&#160;&#177;&#160;0&#46;1</td><td>&#8722;0&#46;2&#160;&#177;&#160;0&#46;1</td><td>0&#46;004</td></tr><tr align="left"><td>Post-bronchodilator change&#44; &#37;</td><td>&#8722;15&#46;6&#160;&#177;&#160;18&#46;5</td><td>&#8722;30&#46;3&#160;&#177;&#160;20&#46;4</td><td>NS</td></tr><tr align="left"><td colspan="4">&#160;</td></tr><tr align="left"><td colspan="4"><span class="elsevierStyleItalic">sGaw</span></td></tr><tr align="left"><td>Baseline&#44; 1&#47;&#40;kPa&#160;s&#41;</td><td>0&#46;7&#160;&#177;&#160;0&#46;3</td><td>0&#46;7&#160;&#177;&#160;0&#46;3</td><td>NS</td></tr><tr align="left"><td>Baseline&#44; &#37; of predicted</td><td>77&#46;3&#160;&#177;&#160;37&#46;8</td><td>70&#46;9&#160;&#177;&#160;39&#46;1</td><td>NS</td></tr><tr align="left"><td>Post-bronchodilator&#44; 1&#47;&#40;kPa&#160;s&#41;</td><td>0&#46;9&#160;&#177;&#160;0&#46;5</td><td>1&#46;0&#160;&#177;&#160;0&#46;5</td><td>NS</td></tr><tr align="left"><td>Post-bronchodilator change&#44; 1&#47;&#40;kPa&#160;s&#41;</td><td>0&#46;2&#160;&#177;&#160;0&#46;3</td><td>0&#46;4&#160;&#177;&#160;0&#46;3</td><td>0&#46;002</td></tr><tr align="left"><td>Post-bronchodilator change&#44; &#37;</td><td>28&#46;7&#160;&#177;&#160;27&#46;9</td><td>65&#46;4&#160;&#177;&#160;54&#46;2</td><td>0&#46;000</td></tr></table><p class="elsevierStylePara">a Reversibility of airway obstruction defined according to the ATS&#47;ERS criteria of 2005&#46; BMI&#58; body mass index&#59; FEV1&#58; forced expiratory volume in one second&#59; FVC&#58; forced vital capacity&#59; PEF&#58; peak expiratory flow&#59; FEF&#58; forced expiratory flow&#59; TLC&#58; total lung capacity&#59; RV&#58; residual volume&#59; IC&#58; inspiratory capacity&#59; Raw&#58; airway resistance&#59; sGaw&#58; specific airway conductance&#59; NS&#58; not significant&#46;<br></br></p><a name="sec0045" class="elsevierStyleCrossRefs"></a><span class="elsevierStyleSectionTitle">Lung function and bronchodilator response</span><p class="elsevierStylePara">Lung function characteristics between bronchodilator responders and non-responders are compared in <a href="&#35;t0005" class="elsevierStyleCrossRefs">Table 1</a>&#46; No meaningful variations could be found neither among any of the spirometry nor plethysmography baseline values or among the majority of the baseline percentage values of predicted between the two groups&#46; There was a substantial difference between responders and non-responders regarding the baseline percentage values of predicted of FEV<span class="elsevierStyleInf">1</span>&#44; FVC and IC&#44; with bronchodilator responders exhibiting significantly higher values among these particular variables&#46;</p><p class="elsevierStylePara">After the administration of a short-acting bronchodilator&#44; there were important differences between the absolute change of FVC&#44; FEV<span class="elsevierStyleInf">1</span>&#44; PEF and IC in the two groups&#46; Also&#44; significant percentage increases were observed in all these variables among the responder group&#46; Absolute and percentage decreases occurred in both RV and Raw that were significantly greater in the responder group&#44; but statistical power was found only for the absolute change of Raw and the percentage change of RV&#46;</p><p class="elsevierStylePara">Other changes were also important&#44; like the percentage change of FEF<span class="elsevierStyleInf">25&#8211;75&#37;</span> and the absolute change of TLC&#46;</p><a name="sec0050" class="elsevierStyleCrossRefs"></a><span class="elsevierStyleSectionTitle">Alternative criteria</span><p class="elsevierStylePara">The area under the ROC curve &#40;AUC&#41; was significant for the following criteria&#58; percentage change of PEF&#44; FEF<span class="elsevierStyleInf">25&#8211;75&#37;</span> and sGaw &#40;0&#46;795&#44; 0&#46;779 and 0&#46;731&#44; respectively&#41;&#44; and absolute change of PEF and FEF<span class="elsevierStyleInf">25&#8211;75&#37;</span> &#40;0&#46;793 and 0&#46;747&#44; respectively&#41;&#46; The AUC for the absolute and percentage changes of both RV and IC&#44; and for the absolute change of sGaw were not significant&#46; <a href="&#35;f0005" class="elsevierStyleCrossRefs">Figure 1</a> and <a href="&#35;t0010" class="elsevierStyleCrossRefs">Table 2</a> display graphic and numerical representation&#44; respectively&#44; of AUC values for alternative ventilatory criteria&#46;</p><a name="f0005" class="elsevierStyleCrossRefs"></a><p class="elsevierStylePara"><img src="320v21n02-90393305fig1.jpg" alt="Receiver operating characteristic &#40;ROC&#41; curves were used to assess alternative pulmonary function tests variables that could define a positive bronchodilator response in a population of asthmatic patients&#46; The area under the ROC curve &#40;AUC&#41; was significant &#40;&#62;0&#46;070&#41; for the following criteria&#58; percentage change of PEF&#44; FEF&#60;sub&#62;25&#8211;75&#37;&#60;&#47;sub&#62; and sGaw&#59; and absolute change of PEF and FEF&#60;sub&#62;25&#8211;75&#37;&#60;&#47;sub&#62;&#46; Cutt-off values were attained from the exact curve speck were sensitivity and specificity reached the best correlation&#58; absolute PEF change &#8805;0&#46;4&#160;L&#47;s&#59; percentage PEF change &#8805;8&#37;&#59; absolute FEF&#60;sub&#62;25&#8211;75&#37;&#60;&#47;sub&#62; change &#8805;0&#46;087&#160;L&#47;s&#59; percentage FEF&#60;sub&#62;25&#8211;75&#37;&#60;&#47;sub&#62; change &#8805;27&#37;&#59; and percentage sGaw change &#8805;25&#37;&#46; PEF&#58; peak expiratory flow&#59; FEF&#60;sub&#62;25&#8211;75&#37;&#60;&#47;sub&#62;&#58; maximum mid-forced expiratory flow&#59; IC&#58; inspiratory capacity&#59; Raw&#58; airway resistance&#59; sGaw&#58; specific airway conductance&#46;"></img></p><p class="elsevierStylePara">Figure 1&#46; Receiver operating characteristic &#40;ROC&#41; curves were used to assess alternative pulmonary function tests variables that could define a positive bronchodilator response in a population of asthmatic patients&#46; The area under the ROC curve &#40;AUC&#41; was significant &#40;&#62;0&#46;070&#41; for the following criteria&#58; percentage change of PEF&#44; FEF<span class="elsevierStyleInf">25&#8211;75&#37;</span> and sGaw&#59; and absolute change of PEF and FEF<span class="elsevierStyleInf">25&#8211;75&#37;</span>&#46; Cutt-off values were attained from the exact curve speck were sensitivity and specificity reached the best correlation&#58; absolute PEF change &#8805;0&#46;4&#160;L&#47;s&#59; percentage PEF change &#8805;8&#37;&#59; absolute FEF<span class="elsevierStyleInf">25&#8211;75&#37;</span> change &#8805;0&#46;087&#160;L&#47;s&#59; percentage FEF<span class="elsevierStyleInf">25&#8211;75&#37;</span> change &#8805;27&#37;&#59; and percentage sGaw change &#8805;25&#37;&#46; PEF&#58; peak expiratory flow&#59; FEF<span class="elsevierStyleInf">25&#8211;75&#37;</span>&#58; maximum mid-forced expiratory flow&#59; IC&#58; inspiratory capacity&#59; Raw&#58; airway resistance&#59; sGaw&#58; specific airway conductance&#46;</p><p class="elsevierStylePara">Table 2&#46; Area under the ROC curve &#40;AUC&#41; for alternative lung function criteria to define positive bronchodilator responses&#46;</p><a name="t0010" class="elsevierStyleCrossRefs"></a><p class="elsevierStylePara"></p><table><tr align="left"><td>Variable</td><td>AUC</td></tr><tr align="left"><td>PEF&#44; absolute change</td><td>0&#46;793</td></tr><tr align="left"><td>PEF&#44; &#37; change</td><td>0&#46;795</td></tr><tr align="left"><td>FEF<span class="elsevierStyleInf">25&#8211;75&#37;</span>&#44; absolute change</td><td>0&#46;747</td></tr><tr align="left"><td>FEF<span class="elsevierStyleInf">25&#8211;75&#37;</span>&#44; &#37; change</td><td>0&#46;779</td></tr><tr align="left"><td>IC&#44; absolute change</td><td>NS</td></tr><tr align="left"><td>IC&#44; &#37; change</td><td>NS</td></tr><tr align="left"><td>Raw&#44; absolute change</td><td>NS</td></tr><tr align="left"><td>Raw&#44; &#37; change</td><td>NS</td></tr><tr align="left"><td>sGaw&#44; absolute change</td><td>NS</td></tr><tr align="left"><td>sGaw&#44; &#37; change</td><td>0&#46;731</td></tr></table><p class="elsevierStylePara">PEF&#58; peak expiratory flow&#59; FEF&#58; forced expiratory flow&#59; IC&#58; inspiratory capacity&#59; Raw&#58; airway resistance&#59; sGaw&#58; specific airway conductance&#59; NS&#58; not significant&#46;<br></br></p><p class="elsevierStylePara">Since PEF is a parameter that depends on the individual ability to perform a forced expiratory maneuver&#44; a correlation analysis between this variable and sGaw&#44; an independent parameter&#44; was undertaken and it showed a linear relationship between the two variables &#40;<span class="elsevierStyleItalic">R</span>&#160;&#61;&#160;5&#46;7&#41;&#46;</p><p class="elsevierStylePara">ROC analysis&#44; specifically the best match point between sensitivity and specificity&#44; defined the following cut-off values for the lung function variables with significant AUC&#58; an absolute and percentage change of PEF &#8805;0&#46;4&#160;L&#47;s and &#8805;8&#37;&#59; an absolute and percentage change of FEF<span class="elsevierStyleInf">25&#8211;75&#37;</span> &#8805;0&#46;087&#160;L&#47;s and 27&#37;&#59; and a percentage change of sGaw &#8805;25&#37;&#46; The sensitivity and specificity values for each of these new variables were as follows&#58; 83&#46;7&#37; and 70&#46;0&#37; for the absolute PEF change&#59; 81&#46;6&#37; and 66&#46;0&#37; for the percentage PEF change&#59; 74&#46;0&#37; and 68&#46;0&#37; for the absolute FEF<span class="elsevierStyleInf">25&#8211;75&#37;</span> change&#59; 60&#37; and 88&#46;0&#37; for the percentage change of FEF<span class="elsevierStyleInf">25&#8211;75&#37;</span>&#59; and 84&#46;0&#37; and 56&#46;0&#37; for the percentage sGaw change&#46;</p><p class="elsevierStylePara">Based on the cut-off values defined by ROC analysis&#44; it was found that a large part of the population of asthmatic patients with non-reversible bronchial obstruction according to the criteria of the ATS&#47;ERS showed a positive response based on alternative criteria&#44; seen in <a href="&#35;f0010" class="elsevierStyleCrossRefs">Figure 2</a>&#46; Hence&#44; 47 patients &#40;94&#37;&#41; of the total of 50 patients with positive bronchodilator response by the ATS&#47;ERS criteria also had reversible bronchial obstruction by the new criteria&#46; On the other hand&#44; 36 patients &#40;72&#37;&#41; of the total 50 patients with negative bronchodilator response were reclassified as positive bronchodilators according to at least one of the alternative new criteria&#46; The percentage change of sGaw was the most responsible for detecting bronchodilatation&#44; which was positive in 22 patients &#40;44&#37;&#41;&#44; followed by the percentage change of PEF in 17 patients &#40;34&#37;&#41; and the absolute change of FEF<span class="elsevierStyleInf">25&#8211;75&#37;</span> in 16 patients &#40;32&#37;&#41;&#46; Finally&#44; 10 patients &#40;20&#37;&#41; had a positive absolute change of PEF while 6 patients &#40;12&#37;&#41; had a positive percentage change of FEF<span class="elsevierStyleInf">25&#8211;75&#37;</span>&#46;</p><a name="f0010" class="elsevierStyleCrossRefs"></a><p class="elsevierStylePara"><img src="320v21n02-90393305fig2.jpg" alt="Alternative lung function criteria for assessing bronchodilatation in a population of asthmatic patients classified as negative bronchodilators according to ATS&#47;ERS criteria&#46; Patients without bronchodilatation according to ATS&#47;ERS criteria &#40;&#60;i&#62;n&#60;&#47;i&#62;&#160;&#61;&#160;50&#41; were considered as positive bronchodilators according to new lung function criteria&#46; A total of 36 patients &#40;72&#37;&#41; had at least one positive criteria&#59; 22 patients &#40;44&#37;&#41; had a percentage change of sGaw &#8805;25&#37;&#59; 17 patients &#40;34&#37;&#41; had a percentage change of PEF &#8805;8&#37;&#59; 16 patients &#40;32&#37;&#41; had an absolute change of FEF&#60;sub&#62;25&#8211;75&#37;&#60;&#47;sub&#62; &#8805;0&#46;087&#160;L&#47;s&#59; 10 patients &#40;20&#37;&#41; had an absolute change of PEF &#8805;0&#46;4&#160;L&#47;s&#59; and 6 patients &#40;12&#37;&#41; had a percentage change of FEF&#60;sub&#62;25&#8211;75&#37;&#60;&#47;sub&#62; &#8805;27&#37;&#46; PEF&#58; peak expiratory flow&#59; FEF&#60;sub&#62;25&#8211;75&#37;&#60;&#47;sub&#62;&#58; maximum mid-forced expiratory flow&#59; IC&#58; inspiratory capacity&#59; Raw&#58; airway resistance&#59; sGaw&#58; specific airway conductance&#46;"></img></p><p class="elsevierStylePara">Figure 2&#46; Alternative lung function criteria for assessing bronchodilatation in a population of asthmatic patients classified as negative bronchodilators according to ATS&#47;ERS criteria&#46; Patients without bronchodilatation according to ATS&#47;ERS criteria &#40;<span class="elsevierStyleItalic">n</span>&#160;&#61;&#160;50&#41; were considered as positive bronchodilators according to new lung function criteria&#46; A total of 36 patients &#40;72&#37;&#41; had at least one positive criteria&#59; 22 patients &#40;44&#37;&#41; had a percentage change of sGaw &#8805;25&#37;&#59; 17 patients &#40;34&#37;&#41; had a percentage change of PEF &#8805;8&#37;&#59; 16 patients &#40;32&#37;&#41; had an absolute change of FEF<span class="elsevierStyleInf">25&#8211;75&#37;</span> &#8805;0&#46;087&#160;L&#47;s&#59; 10 patients &#40;20&#37;&#41; had an absolute change of PEF &#8805;0&#46;4&#160;L&#47;s&#59; and 6 patients &#40;12&#37;&#41; had a percentage change of FEF<span class="elsevierStyleInf">25&#8211;75&#37;</span> &#8805;27&#37;&#46; PEF&#58; peak expiratory flow&#59; FEF<span class="elsevierStyleInf">25&#8211;75&#37;</span>&#58; maximum mid-forced expiratory flow&#59; IC&#58; inspiratory capacity&#59; Raw&#58; airway resistance&#59; sGaw&#58; specific airway conductance&#46;</p><a name="sec0055" class="elsevierStyleCrossRefs"></a><span class="elsevierStyleSectionTitle">Discussion</span><p class="elsevierStylePara">Asthma is a worldwide disease with an increasing incidence and significant burden&#46; Although the diagnosis of asthma is primarily based on clinical grounds&#44; measurement of pulmonary function and particularly the assessment of bronchodilator response is essential for the confirmation and assessment of the disease&#46;<a href="&#35;bib26" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">1</span></a><span class="elsevierStyleSup">&#44; </span><a href="&#35;bib27" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">2</span></a></p><p class="elsevierStylePara">International guidelines define significant bronchodilator response as absolute and percentage changes in FEV<span class="elsevierStyleInf">1</span> and FVC&#44; but these variables may be insufficient to identify all the asthmatic patients who exhibit some degree of airway obstruction reversibility&#46;<a href="&#35;bib47" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">22</span></a> Therefore&#44; we aimed to determine the bronchodilator effects on other lung function parameters besides FEV<span class="elsevierStyleInf">1</span> and FVC&#44; and its ability to detect functional responses to bronchodilator in asthmatic patients&#46;</p><p class="elsevierStylePara">The postbronchodilator percentage variation of PEF&#44; FEF<span class="elsevierStyleInf">25&#8211;75&#37;</span> and sGaw had a significant value of AUC on ROC curves&#44; which confirms its usefulness as alternative criteria of bronchodilator positivity&#46; The same was also verified for the absolute change of PEF and FEF<span class="elsevierStyleInf">25&#8211;75&#37;</span> but not for absolute change of sGaw&#46; The absolute and percentage changes in both RV and Raw did not prove to be good enough tests to assess bronchodilator response&#46;</p><p class="elsevierStylePara">Based on the cut-off values defined by the ROC curves&#44; it was possible to show that a sizeable proportion &#40;72&#37;&#41; of the asthmatic patients without reversibility of bronchial obstruction according to the criteria of the ATS&#47;ERS 2005 guidelines had a positive response based on alternative criteria&#46; The percentage change of sGaw was the most sensitive test for assessing bronchodilatation&#44; followed by the absolute and percentage change of PEF&#46; The absolute and percentage change of FEF<span class="elsevierStyleInf">25&#8211;75&#37;</span> were the least sensitive tests&#46;</p><p class="elsevierStylePara">Some of our findings do not entirely correlate with previous studies published by Light et al&#46;<a href="&#35;bib48" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">23</span></a> concerning Raw and sGaw&#46; Despite the fact that Raw and sGaw did not add significant information in that study&#44; these parameters did show a higher sensitivity than FEV<span class="elsevierStyleInf">1</span> and FVC to predict bronchodilator responses&#46; Nevertheless&#44; more recent studies suggest that these parameters can in fact accurately predict FEV<span class="elsevierStyleInf">1</span> reversibility&#44; but these have been carried out mostly among children and adolescent populations&#46;<a href="&#35;bib41" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">16</span></a><span class="elsevierStyleSup">&#44; </span><a href="&#35;bib49" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">24</span></a> However&#44; one particular study showed that sGaw and FEF<span class="elsevierStyleInf">25&#8211;75&#37;</span> were the most sensitive pulmonary function measurements to detect bronchodilatation among mild asthmatic patients but these results could not be confirmed in patients with moderate disease&#46;<a href="&#35;bib50" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">25</span></a> Conversely&#44; in our study&#44; both these parameters&#44; particularly sGaw&#44; were able to demonstrate bronchodilator reversibility despite the fact that most of our patients had moderate asthma &#40;FEV1 &#60;80&#37; of predicted&#41;&#46;</p><p class="elsevierStylePara">Regarding PEF&#44; other authors also reported that reversibility of airflow obstruction in patients with obstructive lung diseases could be shown by PEF measurements in a comparable way to those obtained by FEV<span class="elsevierStyleInf">1</span>&#46;<a href="&#35;bib40" class="elsevierStyleCrossRefs"><span class="elsevierStyleSup">15</span></a></p><p class="elsevierStylePara">In our study&#44; FEF<span class="elsevierStyleInf">25&#8211;75&#37;</span> significantly contributed to the assessment of reversibility of airways in asthmatic patients&#46; However&#44; caution should be taken when considering FEF<span class="elsevierStyleInf">25&#8211;75&#37;</span> alone&#59; it only should be contemplated when accompanied by an improvement in FEV<span class="elsevierStyleInf">1</span> and&#47;or FVC&#44; and also&#44; the measurement should be done isovolumetrically&#46;</p><p class="elsevierStylePara">Our study has a number of strengths and limitations&#46; All patients were never-smokers diagnosed with asthma based on clinical grounds&#59; they probably were representative of a typical population of asthmatic patients&#46; Both groups were demographically homogeneous thus avoiding possible bias&#46; Nevertheless&#44; our cohort is number limited and larger samples would be necessary to draw additional conclusions&#46; Another important limitation is the lack of a control group represented by normal subjects without asthma&#46;</p><a name="sec0060" class="elsevierStyleCrossRefs"></a><span class="elsevierStyleSectionTitle">Conclusions</span><p class="elsevierStylePara">Assessment of reversibility is part of the common evaluation of patients with asthma or other obstructive pulmonary diseases&#44; however international criteria may underestimate significant functional responses to bronchodilators in asthmatic patients&#46; Based on our results&#44; attention should be given to other functional parameters but the mainstream of bronchodilator treatment should not obviate the symptomatic improvements reported by each patient&#46;</p><a name="sec0065" class="elsevierStyleCrossRefs"></a><span class="elsevierStyleSectionTitle">Ethical disclosures</span><a name="sec0070" class="elsevierStyleCrossRefs"></a><span class="elsevierStyleSectionTitle">Protection of human and animal subjects</span><p class="elsevierStylePara">The authors declare that no experiments were performed on humans or animals for this study&#46;</p><a name="sec0075" class="elsevierStyleCrossRefs"></a><span class="elsevierStyleSectionTitle">Confidentiality of data</span><p class="elsevierStylePara">The authors declare that they have followed the protocols of their work center on the publication of patient data&#46;</p><a name="sec0080" class="elsevierStyleCrossRefs"></a><span class="elsevierStyleSectionTitle">Right to privacy and informed consent</span><p class="elsevierStylePara">The authors declare that no patient data appear in this article&#46;</p><a name="sec0085" class="elsevierStyleCrossRefs"></a><span class="elsevierStyleSectionTitle">Conflicts of interest</span><p class="elsevierStylePara">The authors have no conflicts of interest to declare&#46;</p><p class="elsevierStylePara">Received 12 May 2014 <br></br>Accepted 5 August 2014 </p><p class="elsevierStylePara">Corresponding author&#46; anafilomena&#64;hotmail&#46;com</p>"
    "pdfFichero" => "320v21n02a90393305pdf001.pdf"
    "tienePdf" => true
    "PalabrasClave" => array:1 [
      "en" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec640992"
          "palabras" => array:4 [
            0 => "Asthma"
            1 => "Pulmonary function tests"
            2 => "Reversibility"
            3 => "Obstruction"
          ]
        ]
      ]
    ]
    "tieneResumen" => true
    "resumen" => array:1 [
      "en" => array:1 [
        "resumen" => "<span class="elsevierStyleSectionTitle">Introduction</span><br/><p class="elsevierStylePara">International guidelines define significant bronchodilator response as absolute and percentage change from baseline in forced expiratory volume &#40;FEV<span class="elsevierStyleInf">1</span>&#41; in the first second and&#47;or forced vital capacity &#40;FVC&#41; &#8805;12&#37; and 200&#160;mL&#46; However&#44; bronchodilator effects on other lung function parameters have also been correlated to some degree of reversible airflow limitation&#46;</p><span class="elsevierStyleSectionTitle">Objectives</span><br/><p class="elsevierStylePara">To determine whether changes in other lung function parameters apart from FEV1 and FVC detect functional responses to bronchodilator in asthmatic patients&#46;</p><span class="elsevierStyleSectionTitle">Materials and methods</span><br/><p class="elsevierStylePara">Spirometry and body plethysmography were performed at baseline conditions and after administration of 400&#160;&#956;g of salbutamol by metered-dose inhaler through a space chamber device in asthmatic patients&#46; Paired <span class="elsevierStyleItalic">t</span>-tests were used to compare lung function parameters between those with and without criteria for reversibility of airway obstruction according to ATS&#47;ERS criteria&#46; Cut-off values were obtained from the corresponding ROC curves&#46; Measurements evaluated were FEV<span class="elsevierStyleInf">1</span>&#44; FVC&#44; maximum mid-forced expiratory flow &#40;FEF<span class="elsevierStyleInf">25&#8211;75&#37;</span>&#41;&#44; residual volume &#40;RV&#41;&#44; inspiratory capacity &#40;IC&#41;&#44; airway resistance &#40;Raw&#41; and specific airway conductance &#40;sGaw&#41;&#46;</p><span class="elsevierStyleSectionTitle">Results</span><br/><p class="elsevierStylePara">From a total of 100 consecutive asthmatics patients &#40;46&#37; of them men&#59; average age 58&#46;7&#160;&#177;&#160;14&#46;1 years&#59; 76&#37; with mild to moderate obstruction&#41;&#44; 50 patients had a significant bronchodilator response&#46; All of these had noteworthy variations &#40;<span class="elsevierStyleItalic">p</span>&#160;&#60;&#160;0&#46;004&#41; in PEF&#44; FEF<span class="elsevierStyleInf">25&#8211;75&#37;</span>&#44; RV&#44; Raw and sGaw&#46; The most accurate in predicting a significant bronchodilator response were the absolute and percentage improvements in PEF &#40;&#8805;0&#46;4&#160;L&#47;s and 8&#37;&#41;&#44; FEF<span class="elsevierStyleInf">25&#8211;75&#37;</span> &#40;&#8805;0&#46;087&#160;L&#47;s and 27&#37;&#41; and the percentage of sGaw compared with that at baseline &#40;&#8805;25&#37;&#41;&#46; Based on these cut-off values&#44; a sizeable number of the patients defined as non-responders had important changes in airway caliber&#46; 17 patients had significant increments in the percentage of PEF and 10 had changes in absolute volume&#59; 6 patients had increments in percentage and 16 in absolute change of FEF<span class="elsevierStyleInf">25&#8211;75&#37;</span>&#59; 22 patients had increments in the percentage change of sGaw&#46;</p><span class="elsevierStyleSectionTitle">Conclusions</span><br/><p class="elsevierStylePara">Changes of FEV<span class="elsevierStyleInf">1</span> and&#47;or FVC may underestimate significant functional response to bronchodilators in asthmatic patients with airway obstruction when considering the change in other lung function parameters&#46;</p>"
      ]
    ]
    "multimedia" => array:4 [
      0 => array:8 [
        "identificador" => "fig1"
        "etiqueta" => "Figure 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "copyright" => "Elsevier Espa&#241;a"
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "320v21n02-90393305fig1.jpg"
            "Alto" => 2638
            "Ancho" => 2546
            "Tamanyo" => 666320
          ]
        ]
        "descripcion" => array:1 [
          "en" => "Receiver operating characteristic &#40;ROC&#41; curves were used to assess alternative pulmonary function tests variables that could define a positive bronchodilator response in a population of asthmatic patients&#46; The area under the ROC curve &#40;AUC&#41; was significant &#40;&#62;0&#46;070&#41; for the following criteria&#58; percentage change of PEF&#44; FEF <span class="elsevierStyleInf">25&#191;75&#37;</span> and sGaw&#59; and absolute change of PEF and FEF <span class="elsevierStyleInf">25&#191;75&#37;</span>&#46; Cutt-off values were attained from the exact curve speck were sensitivity and specificity reached the best correlation&#58; absolute PEF change &#191;0&#46;4&#160;L&#47;s&#59; percentage PEF change &#191;8&#37;&#59; absolute FEF <span class="elsevierStyleInf">25&#191;75&#37;</span> change &#191;0&#46;087&#160;L&#47;s&#59; percentage FEF <span class="elsevierStyleInf">25&#191;75&#37;</span> change &#191;27&#37;&#59; and percentage sGaw change &#191;25&#37;&#46; PEF&#58; peak expiratory flow&#59; FEF <span class="elsevierStyleInf">25&#191;75&#37;</span>&#58; maximum mid-forced expiratory flow&#59; IC&#58; inspiratory capacity&#59; Raw&#58; airway resistance&#59; sGaw&#58; specific airway conductance&#46;"
        ]
      ]
      1 => array:8 [
        "identificador" => "fig2"
        "etiqueta" => "Figure 2"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "copyright" => "Elsevier Espa&#241;a"
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "320v21n02-90393305fig2.jpg"
            "Alto" => 1065
            "Ancho" => 1665
            "Tamanyo" => 175700
          ]
        ]
        "descripcion" => array:1 [
          "en" => "Alternative lung function criteria for assessing bronchodilatation in a population of asthmatic patients classified as negative bronchodilators according to ATS&#47;ERS criteria&#46; Patients without bronchodilatation according to ATS&#47;ERS criteria &#40; <span class="elsevierStyleItalic">n</span>&#160;&#61;&#160;50&#41; were considered as positive bronchodilators according to new lung function criteria&#46; A total of 36 patients &#40;72&#37;&#41; had at least one positive criteria&#59; 22 patients &#40;44&#37;&#41; had a percentage change of sGaw &#191;25&#37;&#59; 17 patients &#40;34&#37;&#41; had a percentage change of PEF &#191;8&#37;&#59; 16 patients &#40;32&#37;&#41; had an absolute change of FEF <span class="elsevierStyleInf">25&#191;75&#37;</span> &#191;0&#46;087&#160;L&#47;s&#59; 10 patients &#40;20&#37;&#41; had an absolute change of PEF &#191;0&#46;4&#160;L&#47;s&#59; and 6 patients &#40;12&#37;&#41; had a percentage change of FEF <span class="elsevierStyleInf">25&#191;75&#37;</span> &#191;27&#37;&#46; PEF&#58; peak expiratory flow&#59; FEF <span class="elsevierStyleInf">25&#191;75&#37;</span>&#58; maximum mid-forced expiratory flow&#59; IC&#58; inspiratory capacity&#59; Raw&#58; airway resistance&#59; sGaw&#58; specific airway conductance&#46;"
        ]
      ]
      2 => array:5 [
        "identificador" => "fig3"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "copyright" => "Elsevier Espa&#241;a"
      ]
      3 => array:5 [
        "identificador" => "fig4"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "copyright" => "Elsevier Espa&#241;a"
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "Bibliography"
      "seccion" => array:1 [
        0 => array:1 [
          "bibliografiaReferencia" => array:25 [
            0 => array:3 [
              "identificador" => "bib26"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Lung mechanics during induced bronchoconstriction. J Appl Physiol. 1996; 81:964-75. "
                  "contribucion" => array:1 [
                    0 => array:3 [
                      "titulo" => "Lung mechanics during induced bronchoconstriction&#46;"
                      "idioma" => "en"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "Pellegrino R"
                            1 => "Wilson O"
                            2 => "Jenouri G"
                            3 => "Rodarte JR&#46;"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:3 [
                        "tituloSerie" => "J Appl Physiol. "
                        "fecha" => "1996"
                        "volumen" => "81:964-75."
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib27"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "GINA report, Global strategy for asthma management and prevention | documents/resources | GINA. Available at: http://www.ginasthma.org/documents/4. "
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "GINA report&#44; Global strategy for asthma management and prevention &#124; documents&#47;resources &#124; GINA&#46; Available at&#58; http&#58;&#47;&#47;www&#46;ginasthma&#46;"
                      "idioma" => "en"
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:1 [
                        "tituloSerie" => "org/documents/4. "
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib28"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Interpretative strategies for lung function tests. Eur Respir J. 2005; 26:948-68. "
                  "contribucion" => array:1 [
                    0 => array:3 [
                      "titulo" => "Interpretative strategies for lung function tests&#46;"
                      "idioma" => "en"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:7 [
                            0 => "Pellegrino R"
                            1 => "Viegi G"
                            2 => "Brusasco V"
                            3 => "Crapo RO"
                            4 => "Burgos F"
                            5 => "Casaburi R"
                            6 => "et-al&#46;"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:4 [
                        "tituloSerie" => "Eur Respir J. "
                        "fecha" => "2005"
                        "volumen" => "26:948-68."
                        "itemHostRev" => array:3 [
                          "pii" => "S0091674909009853"
                          "estado" => "S300"
                          "issn" => "00916749"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib29"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "British guideline on the management of asthma. Thorax. 2003; 58(Suppl. 1):i1-i94. "
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "British guideline on the management of asthma&#46;"
                      "idioma" => "en"
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:3 [
                        "tituloSerie" => "Thorax. "
                        "fecha" => "2003"
                        "volumen" => "58"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib30"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Assessing the reversibility of airway obstruction. Chest. 1998; 114:1607-12. "
                  "contribucion" => array:1 [
                    0 => array:3 [
                      "titulo" => "Assessing the reversibility of airway obstruction&#46;"
                      "idioma" => "en"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "Pellegrino R"
                            1 => "Rodarte JR"
                            2 => "Brusasco V&#46;"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:3 [
                        "tituloSerie" => "Chest. "
                        "fecha" => "1998"
                        "volumen" => "114:1607-12."
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib31"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl. 1993; 16:5-40. "
                  "contribucion" => array:1 [
                    0 => array:3 [
                      "titulo" => "Lung volumes and forced ventilatory flows&#46; Report Working Party Standardization of Lung Function Tests&#44; European Community for Steel and Coal&#46; Official Statement of the European Respiratory Society&#46;"
                      "idioma" => "en"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "Quanjer PH"
                            1 => "Tammeling GJ"
                            2 => "Cotes JE"
                            3 => "Pedersen OF"
                            4 => "Peslin R"
                            5 => "Yernault JC&#46;"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:3 [
                        "tituloSerie" => "Eur Respir J Suppl. "
                        "fecha" => "1993"
                        "volumen" => "16:5-40."
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib32"
              "etiqueta" => "7"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Lung hyperinflation and flow limitation in chronic airway obstruction. Eur Respir J. 1997; 10:543-9. "
                  "contribucion" => array:1 [
                    0 => array:3 [
                      "titulo" => "Lung hyperinflation and flow limitation in chronic airway obstruction&#46;"
                      "idioma" => "en"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "Pellegrino R"
                            1 => "Brusasco V&#46;"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:3 [
                        "tituloSerie" => "Eur Respir J. "
                        "fecha" => "1997"
                        "volumen" => "10:543-9."
                      ]
                    ]
                  ]
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib33"
              "etiqueta" => "8"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Partial flow-volume curves to measure bronchodilator dose–response curves in normal humans. J Appl Physiol. 1981; 50:1193-7. "
                  "contribucion" => array:1 [
                    0 => array:3 [
                      "titulo" => "Partial flow-volume curves to measure bronchodilator dose–response curves in normal humans&#46;"
                      "idioma" => "en"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "Barnes PJ"
                            1 => "Gribbin HR"
                            2 => "Osmanliev D"
                            3 => "Pride NB&#46;"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:3 [
                        "tituloSerie" => "J Appl Physiol. "
                        "fecha" => "1981"
                        "volumen" => "50:1193-7."
                      ]
                    ]
                  ]
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib34"
              "etiqueta" => "9"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Effects of increasing doses of beta-agonists on airway and parenchymal hysteresis. J Appl Physiol. 1990; 68:363-8. "
                  "contribucion" => array:1 [
                    0 => array:3 [
                      "titulo" => "Effects of increasing doses of beta-agonists on airway and parenchymal hysteresis&#46;"
                      "idioma" => "en"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "Wang YT"
                            1 => "Thompson LM"
                            2 => "Ingenito EP"
                            3 => "Ingram RH&#46;"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:3 [
                        "tituloSerie" => "J Appl Physiol. "
                        "fecha" => "1990"
                        "volumen" => "68:363-8."
                      ]
                    ]
                  ]
                ]
              ]
            ]
            9 => array:3 [
              "identificador" => "bib35"
              "etiqueta" => "10"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Partial and maximal expiratory flow-volume curves in normal and asthmatic subjects before and after inhalation of metaproterenol. Chest. 1985; 88:697-702. "
                  "contribucion" => array:1 [
                    0 => array:3 [
                      "titulo" => "Partial and maximal expiratory flow-volume curves in normal and asthmatic subjects before and after inhalation of metaproterenol&#46;"
                      "idioma" => "en"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "Berry RB"
                            1 => "Fairshter RD&#46;"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:3 [
                        "tituloSerie" => "Chest. "
                        "fecha" => "1985"
                        "volumen" => "88:697-702."
                      ]
                    ]
                  ]
                ]
              ]
            ]
            10 => array:3 [
              "identificador" => "bib36"
              "etiqueta" => "11"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Assessment of bronchodilator efficacy in symptomatic COPD: is spirometry useful?. Chest. 2000; 117:42S-7S. "
                  "contribucion" => array:1 [
                    0 => array:3 [
                      "titulo" => "Assessment of bronchodilator efficacy in symptomatic COPD&#58; is spirometry useful&#63;&#46;"
                      "idioma" => "en"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "O’Donnell DE&#46;"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:3 [
                        "tituloSerie" => "Chest. "
                        "fecha" => "2000"
                        "volumen" => "117:42S-7S."
                      ]
                    ]
                  ]
                ]
              ]
            ]
            11 => array:3 [
              "identificador" => "bib37"
              "etiqueta" => "12"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Diagnostic accuracy of the bronchodilator response in children. J Allergy Clin Immunol. 2013; 132:. 554-559.e5. "
                  "contribucion" => array:1 [
                    0 => array:3 [
                      "titulo" => "Diagnostic accuracy of the bronchodilator response in children&#46;"
                      "idioma" => "en"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:7 [
                            0 => "Tse SM"
                            1 => "Gold DR"
                            2 => "Sordillo JE"
                            3 => "Hoffman EB"
                            4 => "Gillman MW"
                            5 => "Rifas-Shiman SL"
                            6 => "et-al&#46;"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:3 [
                        "tituloSerie" => "J Allergy Clin Immunol. "
                        "fecha" => "2013"
                        "volumen" => "132:. 554-559.e5"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            12 => array:3 [
              "identificador" => "bib38"
              "etiqueta" => "13"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Measures of reversibility in response to bronchodilators in chronic airflow obstruction: relation to airway calibre. Thorax. 1991; 46:43-5. "
                  "contribucion" => array:1 [
                    0 => array:3 [
                      "titulo" => "Measures of reversibility in response to bronchodilators in chronic airflow obstruction&#58; relation to airway calibre&#46;"
                      "idioma" => "en"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "Weir DC"
                            1 => "Sherwood Burge P&#46;"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:3 [
                        "tituloSerie" => "Thorax. "
                        "fecha" => "1991"
                        "volumen" => "46:43-5."
                      ]
                    ]
                  ]
                ]
              ]
            ]
            13 => array:3 [
              "identificador" => "bib39"
              "etiqueta" => "14"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Short term variability in FEV1 and bronchodilator responsiveness in patients with obstructive ventilatory defects. Thorax. 1987; 42:487-90. "
                  "contribucion" => array:1 [
                    0 => array:3 [
                      "titulo" => "Short term variability in FEV1 and bronchodilator responsiveness in patients with obstructive ventilatory defects&#46;"
                      "idioma" => "en"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "Tweeddale PM"
                            1 => "Alexander F"
                            2 => "McHardy GJ&#46;"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:4 [
                        "tituloSerie" => "Thorax. "
                        "fecha" => "1987"
                        "volumen" => "42:487-90."
                        "itemHostRev" => array:3 [
                          "pii" => "S1470204513703814"
                          "estado" => "S300"
                          "issn" => "14702045"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            14 => array:3 [
              "identificador" => "bib40"
              "etiqueta" => "15"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Validity of peak expiratory flow measurement in assessing reversibility of airflow obstruction. Thorax. 1992; 47:162-6. "
                  "contribucion" => array:1 [
                    0 => array:3 [
                      "titulo" => "Validity of peak expiratory flow measurement in assessing reversibility of airflow obstruction&#46;"
                      "idioma" => "en"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "Dekker FW"
                            1 => "Schrier AC"
                            2 => "Sterk PJ"
                            3 => "Dijkman JH&#46;"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:3 [
                        "tituloSerie" => "Thorax. "
                        "fecha" => "1992"
                        "volumen" => "47:162-6."
                      ]
                    ]
                  ]
                ]
              ]
            ]
            15 => array:3 [
              "identificador" => "bib41"
              "etiqueta" => "16"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Use of specific airway resistance to assess bronchodilator response in children. Respirology. 2011; 16:666-71. "
                  "contribucion" => array:1 [
                    0 => array:3 [
                      "titulo" => "Use of specific airway resistance to assess bronchodilator response in children&#46;"
                      "idioma" => "en"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "Mahut B"
                            1 => "Peiffer C"
                            2 => "Bokov P"
                            3 => "Delclaux C"
                            4 => "Beydon N&#46;"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:3 [
                        "tituloSerie" => "Respirology. "
                        "fecha" => "2011"
                        "volumen" => "16:666-71."
                      ]
                    ]
                  ]
                ]
              ]
            ]
            16 => array:3 [
              "identificador" => "bib42"
              "etiqueta" => "17"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Plethysmographic measurements of specific airway resistance in young children. Chest J. 2005; 128:355. "
                  "contribucion" => array:1 [
                    0 => array:3 [
                      "titulo" => "Plethysmographic measurements of specific airway resistance in young children&#46;"
                      "idioma" => "en"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "Bisgaard H&#46;"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:3 [
                        "tituloSerie" => "Chest J. "
                        "fecha" => "2005"
                        "volumen" => "128:355."
                      ]
                    ]
                  ]
                ]
              ]
            ]
            17 => array:3 [
              "identificador" => "bib43"
              "etiqueta" => "18"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Standardisation of spirometry. Eur Respir J. 2005; 26:319-38. "
                  "contribucion" => array:1 [
                    0 => array:3 [
                      "titulo" => "Standardisation of spirometry&#46;"
                      "idioma" => "en"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "Miller MR"
                            1 => "et-al&#46;"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:3 [
                        "tituloSerie" => "Eur Respir J. "
                        "fecha" => "2005"
                        "volumen" => "26:319-38."
                      ]
                    ]
                  ]
                ]
              ]
            ]
            18 => array:3 [
              "identificador" => "bib44"
              "etiqueta" => "19"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Standardisation of the measurement of lung volumes. Eur Respir J. 2005; 26:511-22. "
                  "contribucion" => array:1 [
                    0 => array:3 [
                      "titulo" => "Standardisation of the measurement of lung volumes&#46;"
                      "idioma" => "en"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:7 [
                            0 => "Wanger J"
                            1 => "Clausen JL"
                            2 => "Coates A"
                            3 => "Pedersen OF"
                            4 => "Brusasco V"
                            5 => "Burgos F"
                            6 => "et-al&#46;"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:3 [
                        "tituloSerie" => "Eur Respir J. "
                        "fecha" => "2005"
                        "volumen" => "26:511-22."
                      ]
                    ]
                  ]
                ]
              ]
            ]
            19 => array:3 [
              "identificador" => "bib45"
              "etiqueta" => "20"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Lung deposition of hydrofluoroalkane-134a beclomethasone is greater than that of chlorofluorocarbon fluticasone and chlorofluorocarbon beclomethasone: a cross-over study in healthy volunteers. Chest. 2002; 122:510-6. "
                  "contribucion" => array:1 [
                    0 => array:3 [
                      "titulo" => "Lung deposition of hydrofluoroalkane-134a beclomethasone is greater than that of chlorofluorocarbon fluticasone and chlorofluorocarbon beclomethasone&#58; a cross-over study in healthy volunteers&#46;"
                      "idioma" => "en"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "Leach CL"
                            1 => "Davidson PJ"
                            2 => "Hasselquist BE"
                            3 => "Boudreau RJ&#46;"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:3 [
                        "tituloSerie" => "Chest. "
                        "fecha" => "2002"
                        "volumen" => "122:510-6."
                      ]
                    ]
                  ]
                ]
              ]
            ]
            20 => array:3 [
              "identificador" => "bib46"
              "etiqueta" => "21"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Effect of size and disease on estimated deposition of drugs administered using jet nebulization in children with cystic fibrosis. Chest. 2001; 119:1123-30. "
                  "contribucion" => array:1 [
                    0 => array:3 [
                      "titulo" => "Effect of size and disease on estimated deposition of drugs administered using jet nebulization in children with cystic fibrosis&#46;"
                      "idioma" => "en"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "Coates AL"
                            1 => "Allen PD"
                            2 => "MacNeish CF"
                            3 => "Ho SL"
                            4 => "Lands LC&#46;"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:3 [
                        "tituloSerie" => "Chest. "
                        "fecha" => "2001"
                        "volumen" => "119:1123-30."
                      ]
                    ]
                  ]
                ]
              ]
            ]
            21 => array:3 [
              "identificador" => "bib47"
              "etiqueta" => "22"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Acute response to bronchodilator. An imperfect guide for bronchodilator therapy in chronic airflow limitation. Arch Intern Med. 1988; 148:1949-52. "
                  "contribucion" => array:1 [
                    0 => array:3 [
                      "titulo" => "Acute response to bronchodilator&#46; An imperfect guide for bronchodilator therapy in chronic airflow limitation&#46;"
                      "idioma" => "en"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "Guyatt GH"
                            1 => "Townsend M"
                            2 => "Nogradi S"
                            3 => "Pugsley SO"
                            4 => "Keller JL"
                            5 => "Newhouse MT&#46;"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:3 [
                        "tituloSerie" => "Arch Intern Med. "
                        "fecha" => "1988"
                        "volumen" => "148:1949-52."
                      ]
                    ]
                  ]
                ]
              ]
            ]
            22 => array:3 [
              "identificador" => "bib48"
              "etiqueta" => "23"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "The one best test for evaluating the effects of bronchodilator therapy. Chest. 1977; 72:512-6. "
                  "contribucion" => array:1 [
                    0 => array:3 [
                      "titulo" => "The one best test for evaluating the effects of bronchodilator therapy&#46;"
                      "idioma" => "en"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "Light RW"
                            1 => "Conrad SA"
                            2 => "George RB&#46;"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:3 [
                        "tituloSerie" => "Chest. "
                        "fecha" => "1977"
                        "volumen" => "72:512-6."
                      ]
                    ]
                  ]
                ]
              ]
            ]
            23 => array:3 [
              "identificador" => "bib49"
              "etiqueta" => "24"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "Evaluation of the magnitude of the bronchodilator response in children and adolescents with asthma. Chest. 2005; 127:530-5. "
                  "contribucion" => array:1 [
                    0 => array:3 [
                      "titulo" => "Evaluation of the magnitude of the bronchodilator response in children and adolescents with asthma&#46;"
                      "idioma" => "en"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "Bussamra MH"
                            1 => "Cukier A"
                            2 => "Stelmach R"
                            3 => "Rodrigues JC&#46;"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:3 [
                        "tituloSerie" => "Chest. "
                        "fecha" => "2005"
                        "volumen" => "127:530-5."
                      ]
                    ]
                  ]
                ]
              ]
            ]
            24 => array:3 [
              "identificador" => "bib50"
              "etiqueta" => "25"
              "referencia" => array:1 [
                0 => array:3 [
                  "referenciaCompleta" => "A comparison of lung function methods for assessing dose–response effects of salbutamol. Br J Clin Pharmacol. 2004; 58:134-41. "
                  "contribucion" => array:1 [
                    0 => array:3 [
                      "titulo" => "A comparison of lung function methods for assessing dose–response effects of salbutamol&#46;"
                      "idioma" => "en"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "Houghton CM"
                            1 => "Woodcock AA"
                            2 => "Singh D&#46;"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:3 [
                        "tituloSerie" => "Br J Clin Pharmacol. "
                        "fecha" => "2004"
                        "volumen" => "58:134-41."
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/08732159/0000002100000002/v0_201604141148/X087321591593305X/v0_201604141148/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "18133"
    "tipo" => "SECCION"
    "es" => array:2 [
      "titulo" => "Artigos originais"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "es"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/08732159/0000002100000002/v0_201604141148/X087321591593305X/v0_201604141148/en/320v21n02a90393305pdf001.pdf?idApp=UINPBA00004E&text.app=https://journalpulmonology.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X087321591593305X?idApp=UINPBA00004E"
]

Article information

ISSN: 08732159
Original language: English

DOI:10.1016/j.rppnen.2014.08.002

The statistics are updated each day

Year/Month	Html	Pdf	Total

2024 November	11	9	20
2024 October	79	48	127
2024 September	93	35	128
2024 August	118	44	162
2024 July	88	33	121
2024 June	89	61	150
2024 May	86	45	131
2024 April	83	39	122
2024 March	84	35	119
2024 February	47	28	75
2024 January	73	47	120
2023 December	56	33	89
2023 November	59	45	104
2023 October	87	56	143
2023 September	78	38	116
2023 August	89	27	116
2023 July	75	26	101
2023 June	100	21	121
2023 May	118	31	149
2023 April	97	20	117
2023 March	140	33	173
2023 February	109	25	134
2023 January	75	24	99
2022 December	107	58	165
2022 November	110	51	161
2022 October	89	39	128
2022 September	64	33	97
2022 August	71	39	110
2022 July	75	43	118
2022 June	55	39	94
2022 May	78	52	130
2022 April	72	42	114
2022 March	51	40	91
2022 February	56	43	99
2022 January	45	37	82
2021 December	37	43	80
2021 November	49	49	98
2021 October	82	49	131
2021 September	53	37	90
2021 August	66	34	100
2021 July	48	22	70
2021 June	52	34	86
2021 May	72	27	99
2021 April	185	88	273
2021 March	155	40	195
2021 February	102	29	131
2021 January	72	33	105
2020 December	71	45	116
2020 November	59	15	74
2020 October	68	37	105
2020 September	92	25	117
2020 August	109	41	150
2020 July	127	20	147
2020 June	120	22	142
2020 May	112	17	129
2020 April	86	20	106
2020 March	94	11	105
2020 February	102	33	135
2020 January	123	23	146
2019 December	91	17	108
2019 November	75	39	114
2019 October	98	33	131
2019 September	111	26	137
2019 August	179	19	198
2019 July	201	30	231
2019 June	203	25	228
2019 May	197	33	230
2019 April	162	40	202
2019 March	205	18	223
2019 February	203	11	214
2019 January	171	32	203
2018 December	103	11	114
2018 November	27	0	27
2018 October	20	9	29
2018 September	20	9	29
2018 August	37	25	62
2018 July	24	20	44
2018 June	24	13	37
2018 May	27	18	45
2018 April	52	20	72
2018 March	46	12	58
2018 February	11	7	18
2018 January	16	11	27
2017 December	24	48	72
2017 November	29	24	53
2017 October	26	16	42
2017 September	15	17	32
2017 August	15	8	23
2017 July	15	10	25
2017 June	16	14	30
2017 May	17	10	27
2017 April	6	10	16
2017 March	7	8	15
2017 February	8	3	11
2017 January	6	4	10
2016 December	8	3	11
2016 November	6	3	9
2016 October	10	1	11
2016 September	18	0	18
2016 August	6	2	8
2016 July	3	9	12
2016 June	0	7	7
2016 May	0	11	11
2016 April	29	1	30
2016 March	45	31	76
2016 February	53	34	87
2016 January	45	21	66
2015 December	41	24	65
2015 November	40	19	59
2015 October	25	23	48
2015 September	41	21	62
2015 August	46	23	69
2015 July	36	10	46
2015 June	46	19	65
2015 May	63	29	92
2015 April	143	78	221
2015 March	125	93	218

Show all

Indexed in:

Follow us:

Statistics

Indexed in:

Follow us:

Statistics

Subscribe to our newsletter